ethinyl estradiol has been researched along with desogestrel in 606 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 103 (17.00) | 18.7374 |
1990's | 198 (32.67) | 18.2507 |
2000's | 168 (27.72) | 29.6817 |
2010's | 119 (19.64) | 24.3611 |
2020's | 18 (2.97) | 2.80 |
Authors | Studies |
---|---|
Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Erkkola, R; Lammintausta, R; Liukko, P | 1 |
Bilotta, P; Favilli, S | 3 |
Jung-Hoffmann, C; Kuhl, H; Storch, A | 1 |
Kvenild, K; Maltau, JM; Oian, P; Strand, H; Tollan, A | 1 |
Eden, S; Karlsson, R; von Schoultz, B | 2 |
Bäckström, T; Cavalli-Björkman, B; Hansson-Malmström, Y; Lindhe, BA; Nordenström, S | 1 |
Coelingh-Bennink, HJ; Davies, GC; Dieben, TO; Feng, LX; Newton, JR | 2 |
Walling, M | 1 |
Larsson, G; Lindstedt, G; Milsom, I; Rybo, G | 1 |
Brändle, E; Gottwald, E; Melzer, H; Sieberth, HG | 1 |
Kauppinen-Mäkelin, R; Kuusi, T; Tikkanen, MJ; Ylikorkala, O | 1 |
Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
Girolami, A; Lazzaro, AR; Simioni, P | 1 |
Fitzner, M; Jung-Hoffmann, C; Kuhl, H | 2 |
Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
Bergbrant, A; Kutti, J; Mattsson, LA | 1 |
Dibbelt, L; Heimann, S; Jütting, G; Klipping, CO; Knuppen, R; Parikka-Olexik, H | 1 |
Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
Berger, GM; Maritz, JS; Sapire, KE | 1 |
Huber, PR; Mall-Haefeli, M; Werner-Zodrow, I | 1 |
Csemiczky, G; Landgren, BM | 1 |
D'Arrigo, F; Granata, A; Granese, D; Nicita, R; Panacea, A; Pullè, C; Sobbrio, GA; Trimarchi, F | 1 |
Back, DJ; Green, S; Orme, M; Ward, S | 1 |
de Voogd, WS | 1 |
D'Antona, D; De Leo, V; Lanzetta, D; Severi, FM; Vanni, AL | 1 |
Haeberli, A; Inauen, W; Stocker, G; Straub, PW | 1 |
Pedersen, RG; Petersen, KR; Skouby, SO | 1 |
Lammers, P; op ten Berg, M | 1 |
Babor, P; Feichtinger, W; Herczeg, KM; Heyda, M; Hoffmann, R; Plöckinger, B; Steinhauser, B | 1 |
Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
Coelingh Bennink, HJ; Dieben, TO; van Beek, A | 1 |
Back, D; Kuhnz, W; Louton, T; Power, J; Schütt, B | 1 |
Back, DJ; Madden, S; Orme, ML | 2 |
Gross, W; Heidt, F; Jung-Hoffmann, C; Kuhl, H; März, W | 2 |
Brill, K; Heithecker, R; Hümpel, M; Kuhnz, W; Louton, T; Pfeffer, M; Schütt, B; Seifert, W; Steinberg, B; Täuber, U | 1 |
de Boer, R; Dersjant-Roorda, MC; Gevers Leuven, JA; Havekes, L; Helmerhorst, FM; Neymeyer-Leloux, A | 1 |
Kloosterboer, HJ; Rekers, H | 1 |
Gaspard, UJ; Humblet, DM; Jaminet, CB; Jandrain, BJ; Lefebvre, PJ; Scheen, AJ | 1 |
David, JL; Gaspard, UJ; Gillain, D; Lepot, MR; Raskinet, R | 1 |
Bonnar, J; Daly, L | 1 |
Brill, K; Heithecker, R; Hümpel, M; Kuhnz, W; Louton, T; Pfeffer, M; Steinberg, B; Tüber, U | 1 |
Gansau, C; Hümpel, M; Kuhnz, W; Louton, T; Schütt, B; Steinberg, B | 1 |
de Boer, R; Dersjant-Roorda, MC; Havekes, LM; Helmerhorst, FM; Leuven, JA; Neymeyer-Leloux, A | 1 |
Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
Jung-Hoffman, C; Kuhl, H | 1 |
Jung-Hoffmann, C; Kuhl, H | 3 |
Bilotta, P; Calabresi, L; Franceschini, G; Gianfranceschi, G; Sirtori, CR; Winkler, S; Zampetti, A; Zoppi, F | 1 |
Alapiessa, U; Apter, D; Assendorp, R; Cacciatore, B; Stenman, UH | 1 |
Daume, E | 1 |
Bernsen, MJ; Dersjant-Roorda, MC; Gevers Leuven, JA; Harthoorn-Lasthuizen, EJ; Helmerhorst, FM; Kluft, C; Peters, FP | 1 |
Apter, D; Timmer, CJ; Voortman, G | 1 |
Odlind, V; Olsson, SE | 1 |
al-Yacoub, G; Kuhnz, W; Pfeffer, M | 1 |
Kivinén, S; Palatsi, R; Reinilä, M | 1 |
Liew, D; Prasad, RN; Ratnam, SS | 1 |
Back, DJ; Madden, S; Martin, CA; Orme, ML | 1 |
Koh, S; Prasad, RN; Ratnam, SS | 1 |
Bertolotto, A; Fioretti, P; Fruzzetti, F; Giampietro, O; Melis, G; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C | 1 |
Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
Defoort, P; Derom, R; Duvivier, P; Kermans, G; Parewijck, W; Schoofs, P; Thiery, M; Van Kets, H; Van Trappen, Y | 1 |
Elstein, M; Eyong, E; Killick, SR; Priddy, AR | 1 |
Alvarado, M; Brito, V; Yabur, JA | 1 |
Bantel, E; Grosshans, E; Ortonne, JP | 1 |
Benagiano, G | 1 |
Christie, T | 1 |
Chez, RA | 1 |
de Pagter, HA; Dersjant-Roorda, MA; Helmerhorst, FA; Leuven, JA; Roelofsen, J | 1 |
Ruutiainen, K | 1 |
Bonnar, J; Carroll, E; Daly, L | 1 |
Gahn, G; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
Gahn, G; Gross, W; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
Althoff, PH; Gahn, G; Kuhl, H; Romberg, G; Taubert, HD | 1 |
Ide, P; Wynants, P | 1 |
De Meyts, P; Gaspard, UJ; Grigorescu, F; Lefèbvre, PJ; Luyckx, AS; Romus, MA | 1 |
Bonnar, J; Sabra, AM | 1 |
Mall-Haefeli, M | 1 |
Bosch, AM; Hasenack, HG; Käär, K | 1 |
Kloosterboer, HJ; van den Ende, A; van Wayjen, RG | 1 |
Caster, H; De Keersgieter, W; Rosseneu, M; Voorhoof, L | 1 |
Galán, G; Gayán, P; Tisné, L | 1 |
Palsma, DM; Ruben, AT; van Berge Henegouwen, GP; van der Werf, SD | 1 |
Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
Cerri, M; Fioretti, P; Fruzzetti, F; Melis, GB; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C | 1 |
Farace, MJ; Leone, F; Minutolo, M; Montemagno, U; Nappi, C; Tommaselli, AP | 1 |
Chailurkit, L; Chaturachinda, K; Rojanasakul, A; Sirimongkolkasem, R | 1 |
Back, DJ; Grimmer, SF; Orme, ML; Shenoy, N | 1 |
Bonnar, J | 1 |
Rabe, T; Runnebaum, B | 1 |
Galimberti, D | 1 |
Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
Hauser, GA | 1 |
Fotherby, K | 3 |
Chailurkit, L; Chaturachinda, K; Piromsawasdi, S; Rojanasakul, A; Sirimongkolkasem, R; Sumavong, V | 1 |
Falsetti, L; Prandini, BD; Schivardi, MR | 1 |
Erkkola, R; Grönroos, M; Järnström, S; Liukko, P; Näntö, V; Pakarinen, P | 1 |
Bergink, EW; Erkkola, R; Liukko, P | 1 |
Bernabei, A; Capitani, S; Massafra, C; Scillone, L | 1 |
Desager, JP; Gaspard, U; Harvengt, C; Lepot, M | 1 |
Alovisi, C; Pacilli, L | 1 |
Bassi, P; Cocilovo, G; Ferrari, C; Guerra, S; Guzzinati, N; Mollica, G; Pansini, F | 1 |
Heidt, F; Jung-Hoffmann, C; Kuhl, H | 2 |
Dreisler, A; Kühl, C; Rubeck Petersen, K; Skouby, SO; Svenstrup, B | 1 |
Cullberg, G; Mattsson, LA | 1 |
Rekers, H | 1 |
Avitto, P; Di Salvo, G; Galati, G; Lapiana, C; Lubrano, R; Martino, F | 1 |
Amedeo, M; Crivello, T; Ferraris, G; Petrelli, P; Porcelli, A; Surico, N | 1 |
Assendorp, R; Dieben, TO; Kopera, H; Steffensen, K | 1 |
D'Errico, G; Minisci, N; Negri, P; Tomasi, A | 1 |
Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
Anderson, DC; Dewis, P; Newman, M; Petsos, P | 1 |
Demeter, J; Gáti, I; Gerö, G; Rákóczi, I | 1 |
Buret, J; Gaspard, UJ; Gillain, D; Lambotte, R; Romus, MA | 1 |
Cullberg, G; Hamberger, L; Mattsson, LA; Mobacken, H; Samsioe, G | 2 |
Crona, N; Samsioe, G; Silfverstolpe, G | 2 |
Cullberg, G | 1 |
de Leede, LG; de Nijs, H; Govers, CP | 1 |
Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
Weijers, MJ | 2 |
Bergink, EW; Borglin, NE; Klottrup, P; Liukko, P | 1 |
Samsioe, G | 1 |
Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
Alapiessa, U; Lund, L; Nummi, S; Ruokonen, A; Viinikka, L | 1 |
Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
Demey-Ponsart, E; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D; Romus, MA | 1 |
Dericks-Tan, JS; Koch, P; Taubert, HD | 1 |
Castren, O; Makkonen, M; Penttilä, IM | 1 |
Bergink, EW; Castrén, O; Holma, P; Hulkko, S; Makkonen, M; Penttilä, IM; Pyörälä, T | 1 |
Hammond, GL; Langley, MS; Lund, L; Nummi, S; Robinson, PA | 1 |
Bergink, EW; Kloosterboer, HJ; Lund, L; Nummi, S | 1 |
Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
Carmassi, F; Fioretti, P; Fruzzetti, F; Melis, GB; Paoletti, AM | 1 |
Käär, K; Rhen, K; Tarkkila, T | 1 |
Bergink, EW; Holma, P; Pyörälä, T | 1 |
Dik, M; Eckert, H; Hönes, S; Schindler, AE | 1 |
Poulsen, HK | 1 |
Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
Bloemenkamp, KW; Büller, HR; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
Egarter, C; Huber, J; Putz, M; Speiser, P; Strohmer, H; Wenzl, R | 1 |
Bielfeld, P; Conrad, M; Graf, M; Krüssel, JS; Rudolf, K | 1 |
Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
Daume, E; Doss, MO; Düsterberg, B; Frank, M; Gross, U; Honcamp, M | 1 |
Fitzner, M; Gross, W; Jung-Hoffmann, C; Kuhl, H; März, W | 1 |
Benedetto, C; Covelli, A; de Aloysio, D; Fanizza, G; Gennarelli, G; Mauloni, M; Trossarelli, GF | 1 |
Filippa, N; Gallina, D; Nappi, RE; Perotti, F; Polatti, F | 1 |
Banharnsupawat, L; Charoenvisal, C; Kaewsuk, O; Koetsawang, S; Punnahitanont, S; Singhakovin, S | 1 |
Bocchinfuso, WP; Hammond, GL; Orava, M; Smith, CL; van den Ende, A; van Enk, A | 1 |
Bennink, HJ; Dieben, TO; Theeuwes, A; Vromans, L | 1 |
Bruyniks, N; Kovacs, L; Rákóczi, I | 1 |
Coelingh Bennink, HJ; Dieben, TO; op ten Berg, MT | 1 |
Aglianò, A; Cianci, A; Ciotta, L; Marletta, E; Palumbo, G; Pisana, L | 1 |
Birkhaeuser, MH; Casez, JP; Haenggi, W; Jaeger, P; Lippuner, K | 1 |
Elstein, M; Feichtinger, W; Fitzgerald, C; Lüdicke, F; Müller, U; Spona, J; Williams, C | 1 |
Akerlund, M; Almström, E; Högstedt, S; Nabrink, M | 1 |
Cappagli, B; Fioretti, P; Gambacciani, M; Piaggesi, L; Spinetti, A; Taponeco, F | 1 |
Back, DJ; Daume, E; Hammerstein, J; Neiss, A; Power, J; Schindler, AE; Simon, A; Winkler, U | 1 |
Archer, DF; Lammers, P; Timmer, CJ | 1 |
Shoupe, D | 1 |
Gallardo, E; Onetto, P; Porcile, A; Schächter, D | 1 |
Angioni, S; Deiana, P; Genazzani, AR; Grasso, A; Mauri, A; Silferi, M; Volpe, A | 1 |
Akerlund, M; Røde, A; Westergaard, J | 1 |
Basdevant, A; Conard, J; Degrelle, H; Guy-Grand, B; Guyene, TT; Lapousterle, C; Mayer, M; Pelissier, C | 1 |
Cachrimanidou, AC; Hellberg, D; Nilsson, S; Olsson, SE; Sikström, B; Waldenström, U | 1 |
Crook, D; Felton, C; Godsland, IF; Proudler, AJ; Sidhu, M; Stevenson, JC; Worthington, M | 1 |
Butini, P; Cavion, MA; Colombini, G; Massafra, C; Minuto, SM | 1 |
Crook, D; Felton, CV; Godsland, IF; Proudler, AJ; Stevenson, JC; Worthington, M | 1 |
Stone, S | 1 |
Ajossa, S; Fruzzetti, F; Guerriero, S; Mais, V; Melis, GB; Paoletti, AM | 1 |
Levrier, M | 2 |
Jespersen, J; Petersen, KR; Sidelmann, J; Skouby, SO | 2 |
Janosz, P; Jendryczko, A; Tomala, J | 1 |
Altieri, P; Bottiglioni, F; Covelli, A; de Aloysio, D; Fanizza, G; Mauloni, M; Roncuzzi, A; Trossarelli, GF | 1 |
Berni, S; Buonocore, G; Gioia, D; Giuliani, A; Massafra, C; Vezzosi, P | 1 |
Schindler, AE | 1 |
Alvarez, F; Bassol, S; Brache, V; Coutinho, EM; da Silva, AR; de Acosta, OM; de Souza, JC; Garza Flores, J; Santo, R; Vasquez-Estrada, L | 1 |
Boehm, BO; Jung-Hoffmann, C; Kuhl, H; Weber, J | 1 |
Gross, W; Jung-Hoffmann, C; Kuhl, H; März, W; Siekmeier, R; Weber, J | 1 |
Kaunitz, AM | 3 |
Burkman, RT | 1 |
Stubblefield, PG | 1 |
Genazzani, AD; Genazzani, AR; Silferi, M; Volpe, A | 1 |
Back, DJ; Daume, E; Hammerstein, J; Neiss, A; Schindler, AE; Simon, A; Ward, S; Winkler, UH | 1 |
Back, DJ; Rudland, PS; Wild, MJ | 1 |
Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
Jespersen, J; Petersen, KP; Skouby, SO | 1 |
Dieben, TO; Geurts, TB; Hellstern, P; Weinges, KF; Wenzel, E | 1 |
Rubio Lotvin, B | 2 |
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
Borm, GF; Coenen, CM; Rolland, R; Thomas, CM | 1 |
Teichmann, A | 1 |
Haber, P; Hartard, M; Havelec, L; Jeschke, D | 1 |
Aznar, J; Fernández, MA; Mira, Y; Vayá, A; Villa, P | 1 |
Düsterberg, B; Endrikat, J; Jaques, MA; Mayerhofer, M; Müller, U; Pelissier, C | 1 |
Albring, M; Brill, K; Kustra, E; Schnitker, J; Teichmann, AT; Wojtynek, P | 1 |
Bonnar, J; Norris, LA | 1 |
Cirillo, SJ; Lippman, JS; Lobo, RA; Skinner, JB | 1 |
Mango, D; Manna, P; Miggiano, GA; Ricci, S; Serra, GB | 1 |
Borm, GF; Coenen, CM; Hollanders, JM; Rolland, R; Thomas, CM | 1 |
Durmuşoğlu, F; Erenus, M; Gürbüz, O; Pekin, S; Yücelten, D | 1 |
Massi, D; Massi, GB; Susini, T | 1 |
Fjalland, B; Moller, BM; Moller, SE; Olesen, M | 1 |
Bennink, HC; Dieben, T; Exalto, N; van der Does, J | 1 |
Creinin, MD | 1 |
Higgins, JE; Rosenberg, MJ; Waugh, MS | 1 |
Düsterberg, B; Elstein, M; Feichtinger, W; Lüdicke, F; Müller, U; Spona, J; Sullivan, H | 1 |
Collet, W; Hölscher, T; Schindler, AE; Schulte, H; Winkler, UH; Zierleyn, JP | 1 |
Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
Crosignani, PG; Parazzini, F; Testa, G; Vegetti, W | 1 |
Farmer, RD; Hambleton, IR; Kennedy, JG; Lawrenson, RA; Thompson, CR | 1 |
Brockmeier, J; Carlsson, J; Meierhenrich, R; Miketic, S; Obergassel, L; Sorges, E; Tebbe, U | 1 |
Crook, D | 1 |
Born, J; Fehm, HL; Krug, R; Pietrowsky, R; Stamm, U | 1 |
Stanczyk, FZ | 1 |
Akerlund, M | 1 |
Diffey, B; O'Dea, K; Piers, LS; Soares, MJ | 1 |
Rossmanith, WG; Schramm, G; Steffens, D | 1 |
Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
Blais, L; Cusson, J; Heinemann, L; Lewis, M; Spitzer, WO; Suissa, S | 1 |
Anserini, P; Capitanio, GL; Gaggero, G; Magnasco, A; Remorgida, V; Testa, D | 1 |
Heufelder, AE; Hofbauer, LC; Jelinek, T; Mrozek-Lasota, A; Schworm, HD; Zimmermann, D | 1 |
Gasser, S; Rossmanith, WG; Steffens, D; Thun, B; Wirth, U | 1 |
Bajares, M; Comparato, MR; Yabur, JA | 1 |
Adebayo, GI; Bonnar, J; Devitt, M; Feely, J; Norris, L | 1 |
Engström, BE; Karlsson, FA; Wide, L | 1 |
Freundl, G; Gnoth, C; Godehardt, E; Gödtke, K; Kienle, E | 1 |
Blumenthal, PD; Huggins, GR; Lammers, P | 1 |
Geurts, TB; Kloosterboer, HJ; van den Ende, A | 1 |
Amram, A; Battaglia, C; Cagnacci, A; Volpe, A | 1 |
Nitsche, DC; Rabe, T; Runnebaum, B | 1 |
Ledger, WJ; Saxena, BB; Singh, M; Singh, R; Thomas, D | 1 |
Eick, S; Gräser, T; Klinger, G; Moore, C; Oettel, M; Pfister, W | 1 |
Brosens, I; Deprest, J; Elomaa, K; Lähteenmäki, P; Moorrees, M; Rolland, R; Tuominen, J | 1 |
Speroff, L | 1 |
Berga, SL | 1 |
Davis, A; Fitzgerald, C; Killick, SR | 1 |
Castelo-Branco, C; Martínez de Osaba, MJ; Pons, F; Vanrell, JA | 1 |
Albring, M; Bidlingmaier, F; Brill, K; Siekmann, A; Siekmann, L | 1 |
Freundl, G; Gnoth, CH; Godehardt, E; Gödtke, K; Kienle, E | 1 |
Bahamondes, L; Baracat, EC; da Cunha, DC; de Andrade, RP; de Melo, NR; Guazelli, CA; Halbe, HW; Lemgruber, M; Petracco, A | 1 |
Biljan, MM; Bissonnette, F; Dean, N; Hemmings, R; Mahutte, NG; Tan, SL | 1 |
Serfaty, D; Vree, ML | 1 |
Branigan, EF; Estes, MA | 1 |
Benussi, C; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR | 1 |
Baranowski, W; Jakimiuk, AJ; Jakowicki, JA; Kulik-Rechberger, B; Postawski, K; Rechberger, T; Tomaszewski, J | 1 |
Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
Gjønnaess, H | 1 |
Fauser, BC; van Heusden, AM | 1 |
Bersi, C; Carmassi, F; De Negri, F; Ferrini, L; Fruzzetti, F; Genazzani, AR; Morale, M; Ricci, C | 1 |
Andreas, JO; Bier, U; Daume, E; Hallmann, C; Oberhoff, C; Schindler, AE; Sudik, R; Winkler, UH | 1 |
Archer, DF; Charnock-Jones, DS; Leslie, S; Macpherson, AM; Makkink, WK; Smith, SK | 1 |
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG | 1 |
Chaikittisilpa, S; Dusitsin, N; Limpaphayom, K; Ninlagarn, T; Panyakhamlerd, K; Taechakraichana, N | 1 |
Archer, DF | 1 |
Meyers, A; Rosenberg, MJ; Roy, V | 1 |
Capelle, L; Fohanno, D; Gazzaz, M; Sichez, J | 1 |
Düsterberg, B; Endrikat, J; Gerlinger, C; Ruebig, A; Strowitzki, T | 1 |
Malinova, M; Pekhlivanov, B; Sirakova, I; Ulichkova, E | 1 |
Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
Edsbäcker, S; Seidegård, J; Simonsson, M | 1 |
Buicu, C; Gaspard, U; van den Brûle, F | 1 |
Creatsas, G; Koliopoulos, C; Mastorakos, G | 2 |
Bohlmann, MK; Prifti, S; Rabe, T; Rehberger-Schneider, S | 1 |
Eskes, TK; Ferguson, H; Vree, ML; Wilpshaar, J | 1 |
Avila, S; Escobar-Morreale, HF; Sancho, J | 1 |
Heithecker, R; Helmerhorst, FM; Oelkers, W; Wuttke, W | 1 |
Kluft, C | 1 |
Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Tekelenburg, W; van den Ende, AE | 1 |
Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC | 1 |
Colau, JC | 1 |
Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
Bertoli, G; Di Lieto, A; Mancone, M; Montoneri, C; Perrone, G; Pietrobattista, P; Sbrignadello, C; Tomassini, A; Zarbo, G; Zichella, L | 1 |
Mulders, TM; Timmer, CJ | 1 |
Escobar-Morreale, HF; Lasunción, MA; Sancho, J | 1 |
Archer, DF; Charnock-Jones, DS; Leslie, S; Macpherson, AM; Makkink, WK; Sharkey, AM; Smith, SK | 1 |
Bakas, P; Creatsas, G; Gregoriou, O; Konidaris, S; Mathiopoulos, D; Papadias, K | 1 |
Albornoz, H; Albrecht, G; Alvarado, A; Bahamondes, L; Bassol, S; Celis, C; Cravioto, MC; de Melo, NR; Isaia, B; Kesseru, E; Mendes, J; Montaño, R; Novelli, J; Peralta, O; Petracco, A; Reyes-Marquez, R; Soares, A | 1 |
Damianov, L; Ivanov, S; Kolarov, G; Novachkov, V; Rachev, E | 1 |
Apter, D; Dieben, TO; Mulders, TM; Roumen, FJ | 1 |
Gabriel, HH; Hilberg, T; Müller-Berghaus, G; Nowacki, PE | 1 |
Broekmeulen, CJ; de Gezelle, H; Vartiainen, M | 1 |
Dieben, TO; Mulders, TM | 1 |
Bounds, W; Furs , SA; Guillebaud, J; Johnson, J; Machin, SJ; Mackie, IJ; Piegsa, K | 1 |
Schmidt, J; Vree, ML | 1 |
Jaisamrarn, U; Reinprayoon, D; Virutamasen, P | 1 |
Bijaoui, S; Dupont, G; Foulon, T; Groslambert, P; Laporte, F; Payen, N; Roland, F | 1 |
Brautigam, J; Brueckner, T; Michels, W; Schleussner, E | 1 |
Agnello, C; Caruso, S; Grillo, C; Intelisano, G; Maiolino, L; Serra, A | 1 |
Agarwal, N; Kriplani, A | 1 |
Cronin, M; Düsterberg, B; Endrikat, J; Gerlinger, C; Ruebig, A; Schmidt, W | 1 |
Casals, E; Castelo-Branco, C; Martínez de Osaba, MJ; Pons, F; Vanrell, JA; Vicente, JJ | 1 |
Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
Kruft, MA; van Laarhoven, JA; Vromans, H | 1 |
Bremme, K; Hamsten, A; Silveira, A; van Rooijen, M; von Schoultz, B | 1 |
Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC | 2 |
Algra, A; Grobbee, DE; Kemmeren, JM | 1 |
Brocco, G; Franchini, M; Guidi, G; Lippi, G; Manzato, F | 1 |
Fanelli, M; Laricchia, L; Orsini, G | 1 |
Auerbach, L; Hafner, T; Huber, JC; Panzer, S | 1 |
Carranza-Lira, S; Magaña-Padilla, NR | 1 |
Jaisamrarn, U; Reinprayoon, D; Taneepanichskul, S; Wongwathanavikromn, R | 1 |
Apter, D; Dieben, TO; Roumen, FJ | 1 |
Olsson, SE | 1 |
Ishak, R | 1 |
Belaisch, J; Eliakim, V | 1 |
Sitruk-ware, R | 1 |
Ismail, MT | 1 |
Baharum, Y; Khalid, H; Roshidah, I | 1 |
Porter, C; Rees, MC | 1 |
Alexander, NJ; Hendrix, SL | 1 |
Demeyer, F; Gaspard, UJ; Lefebvre, P; Lüdicke, F; Scheen, A | 1 |
Caruso, S; Cocuzza, S; Farina, M; Intelisano, G; Maiolino, L; Rugolo, S; Serra, A | 1 |
Abetz, L; de la Loge, C; Novák, A; van der Meulen, EA | 1 |
Milsom, I | 1 |
Killick, S | 1 |
Roumen, F | 1 |
Vree, M | 1 |
Szarewski, A | 1 |
Haring, T; Mulders, TM | 1 |
Breitkopf, DM; Nagamani, M; Rosen, MP; Young, SL | 1 |
Breitkopf, DM; Nagamani, M; Rosen, MP | 1 |
Buicu, C; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R; Lefebvre, P; Scheen, A | 1 |
Alexandersen, P; Christiansen, C; Haarbo, J; Jespersen, J; Skouby, SO; Zandberg, P | 1 |
Attanasio, R; Barausse, M; Cozzi, R; Lasio, G; Lodrini, S | 1 |
Koyuncu, FM; Kuscu, NK; Onur, E; Var, A | 1 |
Cagnacci, A; Melis, GB; Orrù, M; Paoletti, AM; Pilloni, M; Renzi, A; Volpe, A | 1 |
Crosignani, PG; De Giorgi, O; Frontino, G; Pasin, R; Pietropaolo, G; Vercellini, P | 1 |
SCHLAFLI, H | 1 |
HEICKEN, K | 1 |
LIND, A | 1 |
HOTZ, G; RINTELEN, F | 1 |
SALVISBERG, H; SCHONENBERGER, F | 1 |
SCHONENBERGER, F | 1 |
HASLINGER, R; HORODYSKI, B; REISS, J | 1 |
Laine, K; Lundgren, S; Palovaara, S; Pelkonen, O; Uusitalo, J | 1 |
Algra, A; Bouma, BN; Curvers, J; Grobbee, DE; Kemmeren, JM; Meijers, JC; Rosing, J; Tans, G | 1 |
Callejo, J; Díaz, J; García, RM; Ruiz, A | 1 |
Gogaeva, EV; Golousenko, IJ; Golubeva, ON; Mejevitinova, EA; Prilepskaya, VN; Serov, VN; Yaglov, VV; Zharov, EV | 1 |
Milchev, N; Uchikova, E | 1 |
Bitzer, J; Drewe, J; Gerber, S; Haschke, M; Pfrunder, A; Schiesser, M | 1 |
Hamerlynck, JV; Knuist, M | 1 |
Helmerhorst, E; Klipping, C; Kluft, C; Spielmann, D; van Aken, B; van der Mooren, MJ | 1 |
Evans, SL; Forinash, AB | 1 |
Dieben, TO; Mulders, TM; van den Heuvel, MW; Verhoeven, CH | 1 |
Dieben, TO; Verhoeven, CH | 1 |
Buicu, C; Desager, JP; Endrikat, J; Gaspard, U; Gerlinger, C; Heithecker, R | 1 |
Dieben, TO; Klimscheffskij, R; Tuppurainen, M; Venhola, M | 1 |
Cedars, MI; Hughes, HD; Lynch, AM; Schlaff, WD; Smith, DL | 1 |
Berenson, AB; Breitkopf, CR; Grady, JJ; Rickert, VI; Thomas, A | 1 |
Ferguson, H; Mulders, JA; Winkler, UH | 1 |
Kulik-Rechberger, B; Pieprzowska-Białek, A; Rechberger, T; Skorupski, P; Tomaszewski, J | 1 |
Ledzhev, I; Milchev, N; Tsvetkova, T; Uchikova, E | 1 |
Bahceci, M; Bahceci, S; Bilge, M; Tuzcu, A; Tuzcu, S | 1 |
Markova, D; Milchev, N; Terzhumanov, R; Uchikova, E | 1 |
Cui, GH; Guo, Y; Xue, SP; Yang, ZJ; Ye, WS | 1 |
del Marmol, V; Gertsen, K; Teichmann, A | 1 |
Agostinis, C; Bonaldi, G; Censori, B; Guagliumi, G; Partziguian, T; Poloni, M | 1 |
Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
Ivanov, S; Sigridov, I | 1 |
Acunzo, G; Bramante, S; Di Carlo, C; Di Spiezio Sardo, A; Greco, E; Guida, M; Nappi, C; Pellicano, M; Sparice, S; Tommaselli, GA | 1 |
Barmat, LI; Chantilis, SJ; Dickey, RP; Hurst, BS | 1 |
Dogterom, P; Thomsen, T; van den Heuvel, MW | 1 |
Gallo, MF; Grimes, DA; Nanda, K; Schulz, KF | 1 |
Antoniou, AG; Christodoulakos, GE; Creatsas, GC; Dontas, IA; Economou, EV; Eleftheriades, MI; Gregoriou, OV; Kouskouni, EE; Lambrinoudaki, IV; Lyritis, GP; Perrea, DN; Raptou, PD | 1 |
Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
Klipping, C; Marr, J | 1 |
Dieben, T; Duijkers, I; Klipping, C; Kuukankorpi, A; Mäkäräinen, L; Massai, R | 1 |
Brundu, B; De Taddei, S; Ghiotto, N; Nappi, G; Nappi, RE; Polatti, F; Sances, G; Sommacal, A | 1 |
Hout, Ji; Miller, L; Verhoeven, CH | 1 |
Sarkar, NN | 1 |
Ayoğlu, F; Barut, A; Bayar, U | 1 |
O'Connell, KJ; Osborne, LM; Westhoff, C | 1 |
Healy, D; Norman, RJ; Rombauts, L | 1 |
Findlay, JK; Fraser, IS; Hickey, M; O'Connor, V; Palmer, D; Salamonsen, LA; Weisberg, E | 2 |
Dieben, TO; Roumen, FJ | 1 |
Endrikat, J; Gerlinger, C; Heithecker, R; Kluft, C; Mulder, SM | 1 |
Cagnacci, A; Paoletti, AM; Renzi, A; Tirelli, A; Volpe, A | 1 |
Hoomans, EH; op ten Berg, MM; Roumen, FJ | 1 |
Radowicki, S; Skórzewska, K; Szlendak, K | 1 |
Bärtsch, P; Dorsch, M; Walter, B; Weiss, C | 1 |
Batashki, I; Gŭrova, A; Markova, D; Mateva, N; Milchev, N; Uchikova, E | 1 |
Aubeny, E; Bastianelli, C; Birkhäuser, MH; Bjertnaes, A; Gruber, CJ; Knudsen, T; Lete, I; Lindh, I; Milsom, I; Rokstad, K | 1 |
Cagiano, R; Sabatini, R | 1 |
Avril, C; Bied-Damon, V; Bständig, B; Cédrin-Durnerin, I; Decanter, C; Hugues, JN; Parneix, I | 1 |
Calonaci, F; Ferretti, C; Gabbanini, M; Luisi, S; Mazzini, M; Petraglia, F; Razzi, S | 1 |
Prezioso, A | 1 |
Banaszewska, B; Duleba, AJ; Dziura, J; Pawelczyk, L; Spaczynski, RZ | 1 |
Ahrendt, HJ; Bastianelli, C; Bitzer, J; Gemzell-Danielsson, K; Gómez, MA; Karskov, B; Milsom, I; Nisand, I; Oeyen, L; Page, G; Urdl, W | 1 |
Barbosa, R; Barreiros, FA; de Araújo, FF; Guazzelli, CA | 1 |
Kubán, V; Matejícek, D | 1 |
Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
Batashki, I; Gŭrova, A; Markova, D; Milchev, N; Uchikova, E | 1 |
Reeves, MF | 1 |
Atlas, M; Gordon, L; Januchowski, R; Thakur, N | 1 |
Arias, RD; Nucatola, DL; Wagner, MS | 1 |
Hund, M; Merki-Feld, GS | 2 |
Chandra, NC; Das, C; Ramakrishnan, G; Rana, A | 1 |
Bischof, P; de Ziegler, D; Fraisse, T; Ibecheole, V; Pillet, C; Streuli, I | 1 |
Blumenthal, P; Madden, T | 1 |
Camacho, DP; Consolaro, ME; Donatti, L; Gasparetto, A; Patussi, EV; Svidzinski, TI | 1 |
Henneman, P; Rensen, PC; Schaap, FG; Smelt, AH; van Dijk, KW | 1 |
HOESSLY, UJ | 1 |
Burkman, RT; Fisher, AC; LaGuardia, KD | 1 |
Andreeva, EN; Chebotnikova, TV; Grigoryan, OR; Grodnitskaya, EE; Melnichenko, GA | 1 |
Batashki, I; Dinov, I; Ivanov, S | 1 |
Fisher, AC; Kluft, C; LaGuardia, KD; Meijer, P | 1 |
Escudero Fernández, JM; Martínez de Osaba Madariaga, MJ; Rabinovich, IH | 1 |
Chai, DC; D'Hooghe, TM; Mwenda, JM; Nyachieo, A; Spiessens, C | 1 |
Balasch, J; Castelo-Branco, C; Gómez, O; Moyano, D | 1 |
Bruni, V; Luisi, S; Petraglia, F; Pontello, V | 1 |
Hait, H; Poindexter, A; Reape, KZ | 1 |
Huang, XF; Lin, JJ; Lin, WQ; Lin, XH; Ye, BL; Zhao, JZ | 1 |
Coffee, A; Kuehl, AL; Kuehl, TJ; Smith, V; Sulak, PJ; Witt, I | 1 |
Cassidenti, DL; Meldrum, DR; Rosen, GF; Wisot, AL; Yee, B | 1 |
Van Houdenhove, B; Veldman, J; Verguts, J | 1 |
Gallo, MF; Grimes, DA; Lopez, LM; Nanda, K; Schulz, KF | 3 |
Shimoni, N; Westhoff, C | 1 |
Barnhart, KT; Charlesworth, S; Creinin, MD; Gracia, CR; Lin, H; Sammel, MD | 1 |
Bauer, S; Brattström, A; Kunter, U; Roots, I; Will-Shahab, L | 1 |
Sudik, R; Winkler, UH | 1 |
Kaplan, PF; Meendering, JR; Miller, NP; Minson, CT; Torgrimson, BN | 1 |
Debski, R; Kotarski, J; Paszkowski, T; Pawelczyk, L; Skrzypulec, V; Tomaszewski, J | 1 |
Cagnacci, A; Ferrari, S; Tirelli, A; Volpe, A; Zanin, R | 2 |
Bhaduri, M; Carr, LK; Dunn, S; Glanc, P | 1 |
Abbiati, A; Barbara, G; Bianchi, S; Fedele, L; Somigliana, E; Vercellini, P | 1 |
Buono, MJ; Martin, JG | 1 |
Taéron, C | 1 |
Bian, ML; Cao, XM; Cheng, LN; Fan, GS; Han, ZY; Huang, ZR; Jing, XP; Li, J; Wu, SY; Xiong, CL; Xiong, ZA; Yue, TF | 1 |
Barbosa, R; Barreiros, FA; de Araújo, FF; Guazzelli, CA; Moron, AF | 1 |
Anttila, L; Kunz, M; Marr, J | 1 |
Berenson, AB; Rahman, M; Wilkinson, G | 1 |
Airee, A; Cobb, D; Guirguis, AB; Zingone, MM | 1 |
Bifulco, G; Di Carlo, C; Formisano, C; Gargano, V; Massaro, M; Nappi, C | 1 |
Barbosa, R; Barreiros, FA; de Araújo, FF; de Assis, F; Guazzelli, CA | 1 |
Gilliam, ML; Godfrey, E; Kozloski, M; Mistretta, S; Neustadt, A; Tilmon, S | 1 |
Cheng-Liang, X; Guang-Sheng, F; Jian, L; Li-Nan, C; Mei-Lu, B; Shu-Ying, W; Tian-Fu, Y; Xiao-Ming, C; Xiao-Ping, J; Zheng-Ai, X; Zi-Rong, H; Zi-Yan, H | 1 |
Andreeva, EN; Dedov, II; Grigoryan, OR; Grodnitskaya, EE; Klinyshkova, EV; Melnichenko, GA | 1 |
Edwardson, J; Jamshidi, R | 1 |
Goulis, DG; Makedos, A; Panidis, D; Papanikolaou, A | 1 |
Höschen, K; Röhm, P; Winkler, UH | 1 |
Weisberg, E | 1 |
Dunne, C; Firoz, T; Malyuk, D | 1 |
Güner, Z; Küçük, M; Odabaşi, AR; Sezer, SD; Yüksel, H | 1 |
Fait, T | 1 |
Agarwal, N; Ammini, AC; Kriplani, A; Kulshrestha, V; Kumar, A; Periyasamy, AJ | 1 |
Cianci, A; De Leo, V; Di Sabatino, A; Morgante, G; Musacchio, MC; Petraglia, F; Scolaro, V | 1 |
Briones-Landa, CH; Bustillos-Alamilla, E; Hernández-Ruiz, MA; Zepeda-Zaragoza, J | 1 |
Berenson, AB; Rahman, M; van den Berg, P; Williams, KJ | 1 |
Sanam, M; Ziba, O | 1 |
Darney, P; Kerns, J | 1 |
Kersh, E; Livingston, L; Luo, W; McNicholl, J; Michael Hendry, R; Mitchell, J; Paul, K; Powell, N; Sweeney, E | 1 |
Ding, CG; Ge, QH; Liu, XF; Zhi, XJ; Zhou, Z | 1 |
Newens, KJ; Przemska, A; Thompson, AK; Vasilopoulou, D; Williams, CM | 1 |
Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
Cleuren, AC; Postmus, I; Reitsma, PH; van Vlijmen, BJ; Vos, HL | 1 |
Bitzer, J | 1 |
El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
Bermejo, A; Garcia-Velasco, JA; Martinez-Salazar, J; Pellicer, A; Requena, A; Ruiz, F | 1 |
Anttila, L; Kunz, M; Marr, J; Neunteufel, W; Petraglia, F | 1 |
Chang, Q; Hei, CC; Liu, Z; Ma, WZ; Qian, XJ; Shen, XS; Xu, ZL | 1 |
Araujo, FF; Barbieri, M; Barbosa, R; Barreiros, FA; Guazzelli, CA; Torloni, MR | 1 |
Arjuman, A; Chandra, NC; Pandey, H | 1 |
Banaszewska, B; Ozegowska, K; Pawelczyk, L; Spaczyński, RZ | 1 |
Alhajri, M; Greenblatt, E; Liu, KE | 1 |
Kolacki, C; Rocco, V | 1 |
Barbieri, M; Barbosa, R; Barreiros, FA; Guazzelli, CA; Torloni, MR | 1 |
Abu Hashim, H; Alsherbini, W; Bazeed, M | 1 |
Basu, R; Bhattacharya, SM; Ghosh, M | 1 |
Burger, HG; Croxatto, HB; Findlay, JK; Fraser, IS; Weisberg, E | 1 |
Arjuman, A; Chandra, NC; Pandey, H; Roy, KK | 1 |
Voelker, R | 1 |
Berg, E; Bremme, K; Hamad, RR; Stenflo, J; Strandberg, K | 1 |
Gai, L; Gai, P; Jia, Y; Liu, Y; Shi, H; Wang, S; Yu, X; Zhang, M | 1 |
Blanco, M; Zamora, D | 1 |
Liang, BA; Lovett, KM; Mackey, TK | 1 |
Cremers, S; Dragoman, M; Mayeda, ER; Petrie, K; Thomas, T; Torgal, AH; Westhoff, CL | 1 |
Horváth, D; Kovács, GL; Lőcsei, Z; Rácz, K; Szabolcs, I; Toldy, E | 1 |
Basha, M; Burrows, LJ; Goldstein, AT | 1 |
Calhoun, A; Ford, S; Pruitt, A | 1 |
Chagas, JK; Gassen, DT; Herter, LD; Schmid, H | 1 |
Cheetham, TC; Connell, FA; Cooper, WO; Davis, D; Graham, DJ; Ouellet-Hellstrom, R; Quesenberry, CP; Sidney, S; Sorel, M | 1 |
Mishell, DR; Roumen, FJ | 1 |
Ahluwalia, J; Ananworanich, J; Chaithongwongwatthana, S; Gorowara, M; Kriengsinyot, R; Landolt, NK; Lange, JM; Phanuphak, N; Pinyakorn, S; Thammajaruk, N; Thongpaeng, P; Ubolyam, S | 1 |
Corbett, ST; Ehdaie, B; Mason, MD; Peters, CA | 1 |
Halilova, N | 1 |
Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R | 1 |
Kallio, S; Piltonen, T; Puurunen, J; Ruokonen, A; Tapanainen, JS; Vaskivuo, T | 1 |
Mansour, D; Shapiro, S; Szarewski, A | 1 |
Cremers, S; Dragoman, M; Petrie, K; Thomas, T; Torgal, A; Westhoff, CL | 1 |
Bateson, D; Briggs, P; McNamee, K | 1 |
Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
Arangino, S; Cagnacci, A; Napolitano, A; Volpe, A; Zanin, R | 1 |
Decanter, C; Dewailly, D; Lefebvre, C; Lefebvre-Khalil, V; Leroy, M; Leroy-Martin, B; Robin, G; Soudan, B; Thomas, P | 1 |
Cuesta, MC; Guerra, S; Lete, I; Marín, JM | 1 |
Clark, MR; Externbrink, A; Friend, DR; Klein, S | 1 |
Dinger, J; Heinemann, K; Möhner, S | 1 |
Ferrero, S; Leone Roberti Maggiore, U; Remorgida, V; Scala, C; Tafi, E; Venturini, PL | 1 |
Cook, RM; Kaplan, D; Rondina, MT; Vo, TL | 1 |
de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
Ahluwalia, J; Ananworanich, J; Chaithongwongwatthana, S; Cremers, S; Kerr, S; Landolt, NK; Lange, JM; Phanuphak, N; Pinyakorn, S; Thammajaruk, N; Thomas, T; Thongpaeng, P; Ubolyam, S | 1 |
Bowden, SA; Henry, RK | 1 |
Altinok, ML; Andersen, M; Glintborg, D; Hermann, AP; Mumm, H; Ravn, P | 1 |
Cogque-Hernandez, G; Garcia-Latorre, EA; Hernandez-Giron, X; Hernandez-Juarez, J; Isordia-Salas, I; Julián-Nacer, R; Majluf-Cruz, A; Moran-Perez, JF; Moreno-Hernandez, M; Palafox-Gomez, R; Rodriguez-Escobedo, MA | 1 |
Ackay, GY; Avşar, AF; Aydoğmus, H; Aydoğmus, S; Celen, E; Keskin, HL; Sivaslioğlu, AA | 1 |
Altinok, ML; Andersen, M; Bruun, JM; Glintborg, D; Mumm, H; Richelsen, B | 1 |
Chiovato, L; Howard, B; Nappi, RE; Paoletti, AM; Ricciotti, N; Volpe, A; Weiss, H | 1 |
Cibarelli, F; Di Spiezio Sardo, A; Gallo, A; Guida, M; Palumbo, AR; Troisi, J | 1 |
Jensen, JT; Nguyen, BT | 1 |
Jongwutiwes, T; Leelaphiwat, S; Lertvikool, S; Rattanasiri, S; Sukprasert, M; Tabcharoen, C; Weerakiet, S | 1 |
Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
Howard, B; Hsieh, J; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
Biason, TP; Goldberg, TB; Kurokawa, CS; Moretto, MR; Nunes, HR; Teixeira, AS | 1 |
Matarasso, A; Myers, RS; Paresi, RJ | 1 |
Pannucci, CJ | 1 |
Altinok, ML; Andersen, M; Glintborg, D; Mumm, H; Sidelmann, JJ | 1 |
Agarwal, N; Bhatla, N; Gupta, M; Kriplani, A; Singh, N | 1 |
Dadaci, M; Ozgur, F; Oztekin, C; Oztekin, PS; Sargon, MF | 1 |
Delaruelle, Z; Honoré, PJ; Santens, P | 1 |
Ackerman, R; Feldman, R; Howard, B; Hsieh, J; Kroll, R; Ricciotti, N; Weiss, H | 1 |
Ananworanich, J; Bunupuradah, T; Cremers, S; Kancheva Landolt, N; Kerr, S; Kosalaraksa, P; Thammajaruk, N; Ubolyam, S; Zott, R | 1 |
Jensen, JT; London, A | 1 |
Feldman, R; Fox, MC; Frenkl, TL; Wang, Y; Yacik, C | 1 |
Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
Gordon, N; Howard, B; Hsieh, J; Peters, K; Ricciotti, N; Weiss, H | 1 |
Chang, Q; Di, W; Fan, GS; Korver, T; Marintcheva-Petrova, M; McCrary Sisk, C; Qin, Y; Ren, M; Su, P; Wang, G; Wu, S; Yacik, C | 1 |
Camões, S; Lopes, C; Rocha, J; Sampaio, J; Tiago, P | 1 |
Agarwal, N; Bhatla, N; Hari, S; Kachhawa, G; Kriplani, A; Kulshrestha, V; Srivastava, A | 1 |
Goel, N; Priya, K; Rajaram, S | 1 |
Barletta, VT; De Angelis, F; De Giglio, L; Fanelli, F; Marinelli, F; Pagano, VA; Pantano, P; Petsas, N; Pozzilli, C; Tomassini, V | 1 |
Adler, Z; Balucani, C; Levine, SR; Piran, P; Selvan, P; Tark, B | 1 |
Lapuente, O; Lete, I; López-Picado, A | 1 |
Desai, M; Evans-Strickfaden, T; Haaland, RE; Holder, A; Huey, MJ; Humwa, F; Makanga, M; McLellan-Lemal, E; Nyagol, B; Oyaro, B; Williams, T | 1 |
Battaglia, B; Battaglia, C; Casadio, P; Guasina, F; Mattioli, M; Morotti, E | 1 |
Beretta, M; Eder, S; Eggenreich, K; Friedrich, M; Froehlich, E; Khinast, JG; Koscher, G; Koutsamanis, I; Nickisch, K; Paudel, A; Roblegg, E; Witschnigg, A | 1 |
Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
Andersen, M; Christensen, MMH; Glintborg, D; Pedersen, AJT; Stage, TB | 1 |
Chaudhary, DV; Gonzalez, FJ; Nair, SG; Patel, BM; Patel, DP; Singhal, P | 1 |
Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
Abbott, K; Alexander, J; Breiter, H; Gallagher, V; Herrold, A; Kramer, N; Lindley, T; Mjaanes, J; Reilly, J | 1 |
Bentov, Y; Casper, RF; Chang, P; Frederic, M; Haas, J; Hershko Klement, A; Nayot, D | 1 |
Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
Agaba, S; Buyze, J; Crucitti, T; De Baetselier, I; Delvaux, T; Jespers, V; Kestelyn, E; Mwambarangwe, L; Ndagijimana, JC; Umulisa, MM; Uwineza, M; van de Wijgert, JHHM; Van Nuil, JI | 1 |
Cruz, SM; Duijkers, I; Fayad, GN; Frenkl, TL; Heger-Mahn, D; Klipping, C; Korver, T | 1 |
Ackerman, KE; Baskaran, C; Bouxsein, ML; Campoverde Reyes, KJ; Eddy, KT; Klibanski, A; Lee, H; Misra, M; Singhal, V; Slattery, M; Toth, A | 1 |
Barra, F; Bertucci, E; Facchinetti, F; Ferrero, S; Grandi, G; Napolitano, A; Sileo, FG | 1 |
Del Savio, MC; Facchinetti, F; Grandi, G; Sammarini, M; Timò, A | 1 |
Barriga Pooley, P; Galán, G; López Berroa, J; Von Hoveling, A | 1 |
Aweeka, F; Baker, P; Berzins, B; Cohn, SE; Coombs, R; Coughlin, K; Cramer, YS; Gingrich, D; Godfrey, C; Haas, DW; Moran, LE; Rosenkranz, SL; Scarsi, KK; Zorrilla, CD | 1 |
Díez, C; Matilla, S; Mueller, A; Regidor, PA | 1 |
Artini, PG; Battaglia, B; Battaglia, C; Casadio, P; Rizzo, R | 1 |
Luan, X; Wang, Y; Zhao, Y | 1 |
Buhler, L; Diamandopoulos, P; Gong, X; Jimenez, LA; Kirkpatrick, CL; Liang, X; Luther, E; Mowery, MD; White, O; Zheng, J | 1 |
Colli, E; Müller, A; Regidor, PA; Sailer, M | 1 |
Hladik, F; Hughes, SM; Johnston, C; Marrazzo, J; Micks, E; Pandey, U | 1 |
Burton, RC; Williams, CE | 2 |
Beath, S; Parkin, CJ; Rasiah, K | 1 |
Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
Biagiotti, C; Capezzuoli, T; Clemenza, S; Esposto, MC; La Torre, F; Orlandi, G; Petraglia, F; Vannuccini, S | 1 |
Güven, AG; Jaferi, L; Pehlivantürk-Kızılkan, M | 1 |
Bisi Rizzo, ADC; Caldeirão, TD; da Silva, CC; Goldberg, TBL; Nunes, HRC; Orsolini, LR; Teixeira, AS | 1 |
Colli, E; Regidor, PA | 1 |
Lazorwitz, A; Sheeder, J | 1 |
49 review(s) available for ethinyl estradiol and desogestrel
Article | Year |
---|---|
Gastrointestinal metabolism of contraceptive steroids.
Topics: Aged; Biological Availability; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Middle Aged; Norgestrel; Norpregnenes; Sulfates | 1990 |
Metabolic aspects of the new low-dose oral contraceptives.
Topics: Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norgestrel; Norpregnenes; Proteins | 1989 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
Oral contraceptives, lipids and cardiovascular disease.
Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking | 1985 |
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel.
Topics: Clinical Trials as Topic; Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans | 1995 |
Clinical review of a monophasic oral contraceptive containing desogestrel and ethinyl estradiol.
Topics: Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Humans; Lipid Metabolism; Menstrual Cycle; Ovulation | 1993 |
[Vaginal contraception with ovarian steroids].
Topics: Administration, Intravaginal; Clinical Trials as Topic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pessaries; Progesterone Congeners | 1993 |
Combined oral contraception with desogestrel/ethinyl estradiol: tolerability profile.
Topics: Acne Vulgaris; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Drug Tolerance; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Weight Gain | 1993 |
Lipid metabolism effects with desogestrel-containing oral contraceptives.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism | 1993 |
The effects on hemostasis of oral contraceptives containing desogestrel.
Topics: Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans | 1993 |
Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Triglycerides | 1996 |
Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.
Topics: Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Norpregnenes; Progesterone Congeners | 1997 |
Developments in contraception: a comprehensive review of Desogen (desogestrel and ethinyl estradiol).
Topics: Contraceptives, Oral; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Patient Satisfaction; Pregnancy; Progesterone Congeners | 1998 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Bleeding problems and progestogen-only contraception.
Topics: Administration, Oral; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners | 2002 |
Complete and robust ovulation inhibition with NuvaRing.
Topics: Biological Availability; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Ovulation Inhibition; Patient Compliance; Vinyl Compounds | 2002 |
Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing.
Topics: Consumer Product Safety; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pregnancy; Pregnancy Rate; Vinyl Compounds | 2002 |
Lower hormone dosage with improved cycle control.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Incidence; Menstrual Cycle; Menstruation Disturbances; Vinyl Compounds | 2002 |
High acceptability and satisfaction with NuvaRing use.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Patient Satisfaction; Vinyl Compounds | 2002 |
New hormonal contraceptives: a comprehensive review of the literature.
Topics: Administration, Cutaneous; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estradiol; Ethinyl Estradiol; Ethisterone; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norgestrel; Oximes | 2003 |
Enhancing oral contraceptive success: the potential of new formulations.
Topics: Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel | 2004 |
The role of combined oral contraceptives in the management of acne and seborrhea.
Topics: Acne Vulgaris; Contraceptives, Oral; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norgestrel; Norpregnenes; Safety; Treatment Outcome | 2004 |
20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Randomized Controlled Trials as Topic | 2005 |
The combined contraceptive vaginal device (NuvaRing): a comprehensive review.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ovulation; Patient Satisfaction; Randomized Controlled Trials as Topic | 2005 |
The combined etonogestrel/ethinyl estradiol contraceptive vaginal ring.
Topics: Animals; Contraception; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2007 |
Contraceptive vaginal ring.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ovulation; Patient Compliance; Patient Satisfaction; Treatment Outcome | 2007 |
Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea.
Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Dysmenorrhea; Ethinyl Estradiol; Fatigue Syndrome, Chronic; Female; Humans; Metrorrhagia; Remission, Spontaneous | 2009 |
20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Randomized Controlled Trials as Topic | 2008 |
Review of the vaginal contraceptive ring (NuvaRing).
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Satisfaction | 2008 |
The contraceptive vaginal ring.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Progestins; Self Administration | 2010 |
Vaginal ring contraception.
Topics: Anti-Retroviral Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Equipment Failure; Ethinyl Estradiol; Female; Humans; Patient Satisfaction | 2011 |
20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Randomized Controlled Trials as Topic | 2011 |
The vaginal ring (NuvaRing®) for contraception in adolescent women.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; Young Adult | 2012 |
Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 μg compared with a 21/7 regimen of desogestrel 150 μg/ethinylestradiol 20 μg: a pooled analysis.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Metrorrhagia; Young Adult | 2011 |
The combined vaginal contraceptive ring, nuvaring, and cerebral venous sinus thrombosis: a case report and review of the literature.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Intrauterine Devices, Medicated; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 2012 |
The effects of hormonal contraceptives on female sexuality: a review.
Topics: Acne Vulgaris; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; Libido; Medroxyprogesterone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin; Sexuality; Vulva; Vulvodynia | 2012 |
The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction.
Topics: Administration, Intravaginal; Contraception Behavior; Contraceptive Agents; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Acceptance of Health Care; Transdermal Patch; Treatment Outcome | 2012 |
Transurethral placement of vaginal contraceptive device in a patient with neurogenic bladder: a case report and review of the literature.
Topics: Contraceptive Devices, Female; Desogestrel; Device Removal; Drug Combinations; Ethinyl Estradiol; Female; Foreign-Body Migration; Humans; Radiography; Ultrasonography; Urethra; Urinary Bladder, Neurogenic; Vagina; Young Adult | 2013 |
Vaginal health in contraceptive vaginal ring users - A review.
Topics: Candidiasis, Vulvovaginal; Colposcopy; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Vagina; Vaginal Discharge; Vaginal Diseases | 2013 |
20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Randomized Controlled Trials as Topic | 2013 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring.
Topics: Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Polyvinyls; Risk | 2014 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Rationale for eliminating the hormone-free interval in modern oral contraceptives.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Follicle | 2016 |
Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans | 2017 |
Hormonal contraception in women with endometriosis: a systematic review.
Topics: Adult; Androstenes; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Humans; Norethindrone; Pelvic Pain; Progestins; Treatment Outcome | 2019 |
Analysis and new contraception frontiers with combined vaginal rings.
Topics: Administration, Intravaginal; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Vaginal Creams, Foams, and Jellies | 2020 |
Safety, efficacy and quality of life of the novel vaginal contraceptive ring containing etonogestrel/ethinylestradiol 11.0/3.474 mg after 3 years of "real life" experience.
Topics: Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Quality of Life; Time Factors | 2020 |
292 trial(s) available for ethinyl estradiol and desogestrel
Article | Year |
---|---|
[A clinical trial of a monophasic contraceptive preparation containing ethinyl estradiol and desogestrel].
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Italy; Menstrual Cycle; Tablets | 1992 |
Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome | 1992 |
A multicenter efficacy and safety study of an oral contraceptive containing 150 micrograms desogestrel and 30 micrograms ethinyl estradiol.
Topics: Adolescent; Adult; Blood; Blood Chemical Analysis; Blood Pressure; Body Mass Index; Breast Diseases; Cervix Uteri; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies | 1992 |
The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
Topics: Adolescent; Adult; Blood Cell Count; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Menstruation | 1992 |
Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipase; Lipoproteins; Liver; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Triglycerides | 1992 |
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
Group comparison of serum ethinyl estradiol, SHBG and CBG levels in 83 women using two low-dose combination oral contraceptives for three months.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Radioimmunoassay; Random Allocation; Sex Hormone-Binding Globulin; Transcortin | 1991 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
The clinical and biochemical effects of two combination oral contraceptive agents.
Topics: Adolescent; Adult; Age Factors; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1991 |
The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Corpus Luteum; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Time Factors | 1991 |
Sex hormone binding globulin, cortisol binding globulin, thyroxine binding globulin, ceruloplasmin: changes in treatment with two oral contraceptives low in oestrogen.
Topics: Carrier Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Serum Globulins; Sex Hormone-Binding Globulin; Testosterone; Thyroxine-Binding Proteins | 1991 |
The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel.
Topics: Administration, Oral; Adult; Analysis of Variance; Biological Availability; Desogestrel; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Infusions, Intravenous; Metabolic Clearance Rate; Norpregnenes; Progesterone Congeners; Radioimmunoassay | 1991 |
Effects of low and high dose oral contraceptives on blood coagulation and thrombogenesis induced by vascular subendothelium exposed to flowing human blood.
Topics: Adolescent; Adult; Alanine Transaminase; Alkaline Phosphatase; Animals; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Blood Cell Count; Blood Coagulation; Blood Platelets; Blood Vessels; Contraceptives, Oral, Combined; Creatinine; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fibrin; Fibrinogen; Hematocrit; Hemoglobins; Humans; Norpregnenes; Partial Thromboplastin Time; Prothrombin Time; Rabbits; Thrombin Time | 1991 |
Desogestrel and gestodene in oral contraceptives: 12 months' assessment of carbohydrate and lipoprotein metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Lipoproteins; Metabolism; Norpregnenes; Prospective Studies; Time Factors | 1991 |
Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Norpregnenes; Progesterone Congeners | 1991 |
[Side effects of oral contraceptives in the first treatment cycle].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Norgestrel; Norpregnenes; Pilot Projects; Prospective Studies; Retrospective Studies | 1991 |
Multicentre study with a new biphasic oral contraceptive containing ethinylestradiol and desogestrel. Report on efficacy, cycle control and adverse experiences with special emphasis on blood pressure and weight.
Topics: Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypertension; Menstrual Cycle; Norpregnenes; Pregnancy | 1991 |
Changes in lipid metabolism during 12 months of treatment with two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Norpregnenes; Phospholipids; Triglycerides | 1990 |
Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of d
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norpregnenes; Progesterone Congeners; Protein Binding; Randomized Controlled Trials as Topic; Reference Values; Sex Hormone-Binding Globulin; Transcortin | 1990 |
Estrogenic effect of gestodene- or desogestrel-containing oral contraceptives on lipoprotein metabolism.
Topics: Adult; Arteriosclerosis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Risk Factors | 1990 |
Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Prospective Studies; Random Allocation; Reference Values | 1990 |
Comparative studies of 30 micrograms ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Humans; Norpregnenes; Progesterone Congeners; Reference Values | 1990 |
Relative bioavailability of ethinyl estradiol from two different oral contraceptive formulations after single oral administration to 18 women in an intraindividual cross-over design.
Topics: Adult; Biological Availability; Chemistry, Pharmaceutical; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes; Random Allocation | 1990 |
Effects of oral contraceptives on lipid metabolism.
Topics: Adult; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Triglycerides | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
Intra- and interindividual variations in contraceptive steroid levels during 12 treatment cycles: no relation to irregular bleedings.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Multivariate Analysis; Norpregnenes; Progesterone Congeners; Uterine Hemorrhage | 1990 |
Clinical performance and endocrine profiles of contraceptive vaginal rings releasing 3-keto-desogestrel and ethinylestradiol.
Topics: Adult; Androstenedione; Contraceptive Devices, Female; Dehydroepiandrosterone; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Ovary; Progesterone; Progestins; Testosterone | 1990 |
Influence of modern low-dose oral contraceptives on hemostasis.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norpregnenes; Prospective Studies | 1990 |
Changes in coagulation and fibrinolysis variables during use of two oral contraceptives containing the same dose of ethinyl estradiol and either gestodene or desogestrel.
Topics: Adult; Blood Coagulation; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor VII; Female; Fibrinolysis; Humans; Norpregnenes; Peptides; Progesterone Congeners; Sex Hormone-Binding Globulin; Tissue Polypeptide Antigen | 1990 |
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Norpregnenes; Pituitary Gland; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
Topics: Adolescent; Adult; Carbohydrate Metabolism; China; Cholesterol; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Lipoproteins; Longitudinal Studies; Norgestrel; Norpregnenes; Prospective Studies; Singapore; Triglycerides | 1989 |
Effects of three types of combined O.C. pills on blood coagulation, fibrinolysis and platelet function.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Blood Platelets; Blood Pressure; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Fibrinolysis; Hematocrit; Humans; Menstrual Cycle; Norgestrel; Norpregnenes; Platelet Aggregation; Progesterone Congeners | 1989 |
Metabolic effects of three new low-dose pills: a six-month experience.
Topics: Adult; Androgen Antagonists; Blood Glucose; Body Weight; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Progesterone Congeners; Random Allocation; Reference Values; Triglycerides | 1989 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
Topics: Adult; Blood Pressure; Body Weight; Breast; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Headache; Humans; Menstrual Cycle; Multicenter Studies as Topic; Nausea; Norpregnenes; Random Allocation | 1989 |
A clinical overview of a new triphasic contraceptive containing gestodene.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Menstrual Cycle; Multicenter Studies as Topic; New Zealand; Norethindrone; Norpregnenes; Patient Compliance; South America | 1989 |
Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins; Norpregnenes; Random Allocation; Triglycerides | 1989 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Random Allocation; Testosterone | 1985 |
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phospholipids; Random Allocation; Triglycerides | 1985 |
Carbohydrate metabolism in women who used oral contraceptives containing levonorgestrel or desogestrel: a 6-month prospective study.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Erythrocytes; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Norgestrel; Norpregnenes; Prospective Studies; Pyruvates; Pyruvic Acid; Random Allocation; Receptor, Insulin | 1986 |
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1986 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Clinical studies with a new, low-dose oral contraceptive combination, containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes | 1987 |
Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies | 1988 |
Ethinylestradiol and desogestrel, alone or in combination with two doses of estriol. Effects on plasma proteins.
Topics: Adolescent; Adult; Blood Proteins; Ceruloplasmin; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Sequential; Desogestrel; Estriol; Ethinyl Estradiol; Female; Humans; Norpregnenes; Prealbumin; Random Allocation; Sex Hormone-Binding Globulin; Thyroxine-Binding Proteins; Transcortin | 1988 |
Multicenter trial of a monophasic oral contraceptive containing ethinyl estradiol and desogestrel.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Norpregnenes | 1988 |
Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Prolactin; Time Factors | 1988 |
[Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism | 1988 |
An oral contraceptive particularly suitable for women over 35.
Topics: Adult; Apolipoproteins A; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Multicenter Studies as Topic; Norpregnenes | 1988 |
Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Time Factors; Triglycerides | 1985 |
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1985 |
Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
Topics: Adult; Androstenedione; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Middle Aged; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Middle Aged; Norpregnenes; Polycystic Ovary Syndrome | 1985 |
[Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Italy; Menstrual Cycle; Norpregnenes; Progesterone Congeners | 1987 |
[Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)].
Topics: Adolescent; Adult; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes | 1982 |
Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Development of an oral contraceptive containing a new progestogen, desogestrel, and 30 micrograms ethinylestradiol. Report on clinical studies from Scandinavia.
Topics: Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Scandinavian and Nordic Countries | 1982 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glycoproteins; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism; Triglycerides | 1984 |
Clinical trial of an oral contraceptive containing desogestrel and ethinyl estradiol.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes; Pregnancy | 1982 |
Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
Topics: Adolescent; Adult; Androgens; Blood Proteins; Ceruloplasmin; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Dihydrotestosterone; Ethinyl Estradiol; Female; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1981 |
Ovarian function during low-dose oral contraceptive use.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Norgestrel; Ovarian Cysts; Ovary; Patient Compliance; Progesterone; Prospective Studies; Smoking; Ultrasonography | 1995 |
[Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lynestrenol; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Remission, Spontaneous; Retrospective Studies; Treatment Outcome | 1995 |
Short- and long-term effects on lipid metabolism of oral contraceptives containing 30 micrograms ethinylestradiol and 150 micrograms desogestrel or 3-keto-desogestrel.
Topics: Adult; Apolipoprotein A-I; Cholesterol; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipoproteins, HDL; Lipoproteins, LDL; Progesterone Congeners; Triglycerides | 1995 |
Prodrug versus drug effects of 150 micrograms desogestrel or 3-keto-desogestrel in combination with 30 micrograms ethinylestradiol on hormonal parameters: relevance of the peak serum level of 3-keto-desogestrel.
Topics: Adult; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Liver; Prodrugs; Progesterone Congeners; Sex Hormone-Binding Globulin; Time Factors | 1995 |
Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol.
Topics: Adult; Aging; Body Mass Index; Climacteric; Contraceptives, Oral, Combined; Depression; Desogestrel; Ethinyl Estradiol; Female; Headache; Humans; Longitudinal Studies; Menstrual Cycle; Middle Aged; Nausea | 1995 |
Bone mass and long-term monophasic oral contraceptive treatment in young women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Prospective Studies | 1995 |
Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
Topics: Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Multicenter Studies as Topic; Norpregnenes; Prospective Studies; Thailand; Uterine Hemorrhage | 1995 |
Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
Topics: Adult; Biological Availability; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Sex Hormone-Binding Globulin; Transcortin | 1994 |
The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1994 |
Multicenter study in Hungary with a 30 micrograms ethinylestradiol- and 150 micrograms desogestrel-containing monophasic oral contraceptive.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hungary; Menstrual Cycle | 1994 |
Cycle control and side effects of a new combiphasic oral contraceptive regimen.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Menstruation Disturbances | 1994 |
Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Gonadal Steroid Hormones; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 1994 |
A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovulation; Pregnancy; Progesterone | 1994 |
Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Topics: Adult; Apolipoproteins; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Phospholipids; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1994 |
Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism.
Topics: Adult; Analysis of Variance; Bone Density; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Middle Aged; Osteoporosis, Postmenopausal; Regression Analysis; Spine | 1994 |
Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives.
Topics: Adolescent; Adult; Blood Proteins; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes; Protein Binding; Sex Hormone-Binding Globulin | 1993 |
Multicenter randomized comparative trial of two low-dose triphasic combined oral contraceptives containing desogestrel or norethindrone.
Topics: Adolescent; Adult; Blood Pressure; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation Disturbances; Norethindrone; Patient Compliance; Pregnancy | 1994 |
Very low estrogen-desogestrel contraceptive in perimenopausal hormonal replacement.
Topics: Cholesterol; Climacteric; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Triglycerides | 1994 |
Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
Topics: Adolescent; Adult; Body Weight; Chemistry, Pharmaceutical; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium; Risk Factors | 1993 |
Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 mcg to 20 mcg in oral contraceptives containing desogestrel.
Topics: Apolipoprotein A-I; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Hemostasis; Humans; Pancuronium; Plasminogen; Prospective Studies; Protein C; Protein S; Renin; Sex Hormone-Binding Globulin; Transcortin; Triglycerides | 1993 |
Long-interval treatment regimen with a desogestrel-containing oral contraceptive.
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Surveys and Questionnaires; Uterine Hemorrhage | 1993 |
Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: a prospective study.
Topics: Absorptiometry, Photon; Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Resorption; Contraceptives, Oral, Hormonal; Creatinine; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydroxyproline; Prospective Studies | 1993 |
[Hemostatic balance during treatment with the newest contraceptives].
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norpregnenes; Prospective Studies | 1994 |
Effects of two low-dose oral contraceptives on erythrocyte superoxide dismutase, catalase and glutathione peroxidase activities.
Topics: Adult; Catalase; Contraceptives, Oral, Hormonal; Desogestrel; Erythrocytes; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Malondialdehyde; Norgestrel; Superoxide Dismutase | 1993 |
The 3-keto-desogestrel/ethinylestradiol ring: a new parenteral form of hormonal contraception.
Topics: Adult; Contraception; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Progesterone Congeners | 1993 |
Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin; Fibrinolysis; Humans; Norpregnenes | 1993 |
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Topics: Administration, Intravaginal; Adolescent; Adult; Desogestrel; Developing Countries; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Patient Acceptance of Health Care; Pregnancy; Random Allocation; Vagina | 1993 |
Contraception in older woman.
Topics: Adult; Blood Coagulation Factors; Bone Density; Breast; Climacteric; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Headache; Humans; Lipids; Longitudinal Studies; Menstrual Cycle; Middle Aged; Nausea; Sex Hormone-Binding Globulin | 1993 |
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Immunoenzyme Techniques; Longitudinal Studies; Norpregnenes; Radioimmunoassay; Time Factors; Transcortin | 1993 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
The effects of two phasic oral contraceptives on hemostasis and platelet function.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel | 1995 |
Comparative evaluation of the androgenicity of four low-dose, fixed-combination oral contraceptives.
Topics: Adult; Androgens; Blood Pressure; Body Weight; Carrier Proteins; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norgestrel; Norpregnenes; Progesterone Congeners; Prospective Studies; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone | 1995 |
Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1995 |
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 20 micrograms ethinylestradiol/150 micrograms desogestrel, with respect to efficacy, cycle control
Topics: Adolescent; Adult; Amenorrhea; Austria; Body Weight; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Tolerance; Dysmenorrhea; Ethinyl Estradiol; Female; France; Headache; Humans; Longitudinal Studies; Menstrual Cycle; Nausea; Norpregnenes; Progesterone Congeners; Time Factors | 1995 |
The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovarian Follicle; Pregnancy; Prospective Studies; Ultrasonography | 1995 |
Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Androstenedione; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Ovary; Sex Hormone-Binding Globulin; Testosterone | 1996 |
Changes in androgens during treatment with four low-dose contraceptives.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Dihydrotestosterone; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hydroxyprogesterones; Luteal Phase; Norgestrel; Norpregnenes; Pancuronium; Progestins; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1996 |
Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyprogesterones; Luteinizing Hormone; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Prospective Studies; Single-Blind Method; Spironolactone; Testosterone | 1996 |
Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Progesterone Congeners; Ultrasonography | 1995 |
The effect of desogestrel, gestodene, and other factors on spotting and bleeding.
Topics: Adolescent; Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners; Smoking; Uterine Hemorrhage | 1996 |
Shorter pill-free interval in combined oral contraceptives decreases follicular development.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovary; Progesterone; Ultrasonography | 1996 |
Ethinylestradiol 20 versus 30 micrograms combined with 150 micrograms desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system.
Topics: Adolescent; Adult; Blood Coagulation Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Estradiol Congeners; Ethinyl Estradiol; Female; Fibrin; Hemostasis; Humans; Middle Aged; Prospective Studies; Thromboembolism | 1996 |
Ovarian activity during regular oral contraceptive use.
Topics: Adult; Contraceptives, Oral; Desogestrel; Endometrium; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Follicle; Ovulation; Progesterone; Progesterone Congeners; Ultrasonography | 1996 |
Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Pregnancy; Progesterone Congeners | 1997 |
A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
Topics: Adult; Cervix Mucus; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Endometrium; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menstrual Cycle; Norethindrone; Ovary; Progesterone; Steroids; Ultrasonography | 1997 |
[Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norethindrone; Ovarian Function Tests; Ovary | 1997 |
Contraceptive efficacy and acceptability of a monophasic oral contraceptive containing 30 microg ethinyl estradiol and 150 microg desogestrel in Latin-American women.
Topics: Acne Vulgaris; Adult; Argentina; Blood Pressure; Body Weight; Contraception; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Incidence; Treatment Outcome; Uterine Hemorrhage; Venezuela | 1998 |
Effects of oral contraceptives containing different progestogens on sodium-lithium countertransport in normal females.
Topics: Adolescent; Adult; Antiporters; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Double-Blind Method; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Progesterone Congeners; Reference Values | 1998 |
Steroidal 'add-back' therapy in patients treated with GnRH agonists.
Topics: Adult; Delayed-Action Preparations; Desogestrel; Double-Blind Method; Endometriosis; Ethinyl Estradiol; Female; Hot Flashes; Humans; Leuprolide; Placebos; Prospective Studies; Sleep Initiation and Maintenance Disorders; Sweating | 1998 |
A randomized cross-over study comparing pharmacodynamic and metabolic variables of a new combiphasic and a well-established triphasic oral contraceptive.
Topics: Antithrombin III; Carbohydrate Metabolism; Carrier Proteins; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Lipid Metabolism; Ovulation; Progesterone; Progesterone Congeners | 1997 |
Biochemical aspects of hormonal contraception: effects on bone metabolism.
Topics: Alkaline Phosphatase; Bone Density; Bone Remodeling; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Creatinine; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Menopause; Middle Aged; Osteocalcin; Progesterone Congeners | 1997 |
The effects of monophasic and triphasic oral contraceptives on ovarian function and endometrial thickness.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Desogestrel; Drug Combinations; Endometrium; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Middle Aged; Norgestrel; Norpregnenes; Ovary; Progesterone | 1997 |
A triphasic oral contraceptive pill, CTR-05: clinical efficacy and safety.
Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Nausea; Norethindrone; Progesterone Congeners | 1996 |
Influence of hormonal contraceptives on microbial flora of gingival sulcus.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gingiva; Humans; Nandrolone; Porphyromonas gingivalis; Prevotella intermedia | 1998 |
Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Menstrual Cycle; Norpregnenes; Ovarian Follicle; Ovulation; Progesterone | 1998 |
An open-label, multicenter, noncomparative safety and efficacy study of Mircette, a low-dose estrogen-progestin oral contraceptive. The Mircette Study Group.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation; Middle Aged | 1998 |
Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Endocrine System; Ethinyl Estradiol; Female; Glucose; Humans; Lipid Metabolism | 1998 |
Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Ovarian Follicle; Progesterone; Reference Values; Ultrasonography | 1998 |
Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements.
Topics: Administration, Oral; Area Under Curve; Biological Availability; Carbon Isotopes; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Mass Spectrometry; Menstrual Cycle; Nifedipine; Norpregnenes; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists.
Topics: Amino Acids; Bone Density; Calcium; Desogestrel; Double-Blind Method; Endometriosis; Ethinyl Estradiol; Female; Humans; Leuprolide; Pelvic Pain; Placebos; Prospective Studies | 1999 |
Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene.
Topics: Acne Vulgaris; Adult; Blood Pressure; Body Weight; Brazil; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners; Severity of Illness Index; Uterine Hemorrhage | 1998 |
A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 micrograms ethinylestradiol and either 150 micrograms desogestrel or 75 micrograms gestodene.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Norpregnenes; Patient Satisfaction; Pregnancy; Progesterone Congeners | 1998 |
Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by repeat CC treatment.
Topics: Adult; Anovulation; Chronic Disease; Clomiphene; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Failure | 1999 |
Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics.
Topics: Adult; Analysis of Variance; Biomarkers; Bone Density; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Hydroxyproline; Longitudinal Studies; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Premenopause; Reference Values; Ultrasonography | 1999 |
Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Ovarian Follicle; Ovary; Pituitary Gland | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
Activation of coagulation in smoking and non-smoking women using a third-generation oral contraceptive containing desogestrel.
Topics: Adolescent; Adult; Analysis of Variance; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Prothrombin; Reference Values; Sensitivity and Specificity; Smoking | 1999 |
A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Female; Hemostasis; Humans; Progesterone Congeners; Protein C; Prothrombin; Reference Values; Single-Blind Method; Statistics, Nonparametric | 1999 |
The effect of etonogestrel on VEGF, oestrogen and progesterone receptor immunoreactivity and endothelial cell number in human endometrium.
Topics: Adolescent; Adult; Cell Count; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Endometrium; Endothelial Growth Factors; Endothelium; Ethinyl Estradiol; Female; Humans; Immunohistochemistry; Lymphokines; Menstrual Cycle; Menstruation; Middle Aged; Receptors, Estrogen; Receptors, Progesterone; Reference Values; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinyl Compounds | 1999 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism | 1999 |
A randomized trial of oral contraceptive and hormone replacement therapy on bone mineral density and coronary heart disease risk factors in postmenopausal women.
Topics: Adult; Bone Density; Contraceptives, Oral; Coronary Disease; Desogestrel; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Medrogestone; Middle Aged; Postmenopause; Progesterone Congeners; Risk Factors | 2000 |
Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations.
Topics: Adolescent; Adult; Breast; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hormones; Humans; Menstrual Cycle; Middle Aged; Nausea; Norgestrel; Pregnancy; Statistics, Nonparametric; Uterine Hemorrhage | 1999 |
Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Pregnancy; Progesterone Congeners; Prospective Studies; Uterine Hemorrhage | 1999 |
Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol.
Topics: Administration, Oral; Adult; Area Under Curve; Budesonide; Chromatography, High Pressure Liquid; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Drug Interactions; Estradiol Congeners; Ethinyl Estradiol; Female; Glucocorticoids; Humans; Hydrocortisone; Prednisolone; Single-Blind Method | 2000 |
Combined oral contraceptive treatment of adolescent girls with polycystic ovary syndrome. Lipid profile.
Topics: Adolescent; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome | 2000 |
Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Netherlands; Progesterone Congeners | 2000 |
Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Luminescent Measurements; Prostate-Specific Antigen | 2000 |
Efficacy, cycle control, and safety of two triphasic oral contraceptives: Cyclessa (desogestrel/ethinyl estradiol) and ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol): a randomized clinical trial.
Topics: Adolescent; Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Mestranol; Middle Aged; Norethindrone; Pregnancy; Treatment Failure; Uterine Hemorrhage; Weight Gain | 2000 |
Effect of an oral contraceptive containing drospirenone on the renin-angiotensin-aldosterone system in healthy female volunteers.
Topics: Adolescent; Adult; Aldosterone; Androstenes; Angiotensinogen; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Renin; Renin-Angiotensin System | 2000 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Biomarkers; Blood Proteins; Carboxypeptidase B2; Carboxypeptidases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; Levonorgestrel; Netherlands; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Tissue Plasminogen Activator | 2000 |
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia | 2000 |
Comparative study on the acceptability of two modern monophasic oral contraceptive preparations: 30 microgram ethinyl estradiol combined with 150 microgram desogestrel or 75 microgram gestodene.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners; Prospective Studies | 1999 |
Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Vinyl Compounds | 2000 |
Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.
Topics: Adult; Apolipoproteins B; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Insulin Resistance; Lipids; Lipoprotein(a); Triglycerides | 2000 |
The effect of combined oral contraception with or without spironolactone on bone mineral density of hyperandrogenic women.
Topics: Adult; Alkaline Phosphatase; Bone Density; Calcium; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hydroxyproline; Hyperandrogenism; Luteinizing Hormone; Osteocalcin; Phosphates; Spironolactone | 2000 |
Latin american experience with two low-dose oral contraceptives containing 30 microg ethinylestradiol/75 microg gestodene and 20 microg ethinylestradiol/150 microg desogestrel.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Headache; Humans; Latin America; Norpregnenes; Pregnancy; Weight Gain | 2000 |
[Mercilon - the optimal oral contraceptive].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kidney Function Tests; Lipids; Liver Function Tests; Menstrual Cycle; Pregnancy; Pregnancy Rate; Time Factors | 2000 |
Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives.
Topics: Adult; Analysis of Variance; Blood Coagulation; Conditioning, Psychological; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Exercise Test; Female; Fibrinolysis; Humans; Levonorgestrel; Physical Education and Training; Physical Exertion; Probability; Reference Values; Thrombophilia | 2000 |
Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Severity of Illness Index | 2001 |
Use of the novel combined contraceptive vaginal ring NuvaRing for ovulation inhibition.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Ovarian Follicle; Ovulation; Progesterone; Time Factors; Ultrasonography; Vinyl Compounds | 2001 |
A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany.
Topics: Acne Vulgaris; Administration, Oral; Adolescent; Adult; Cohort Studies; Contraception Behavior; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Germany; Humans; Menstrual Cycle; Middle Aged; Patient Satisfaction | 2001 |
Clinical study of a monophasic pill containing 20 microg ethinylestradiol and 150 microg desogestrel in Thai women.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Evaluation Studies as Topic; Female; Humans; Pregnancy; Pregnancy Rate; Sensitivity and Specificity; Thailand; Treatment Outcome | 2001 |
Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins | 2001 |
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 20 microg ethinyl estradiol and 150 microg desogestrel.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2001 |
Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.
Topics: Absorptiometry, Photon; Administration, Oral; Adult; Bone Density; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Hypothalamic Diseases; Oligomenorrhea | 2001 |
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.
Topics: Adult; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Factor VII; Factor VIIa; Female; Humans; Levonorgestrel; Lipoproteins; Peptide Fragments; Prospective Studies; Prothrombin; Triglycerides | 2002 |
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia | 2002 |
Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins, HDL; Point Mutation; Progesterone Congeners; Triglycerides | 2001 |
Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Apolipoprotein A-I; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Polycystic Ovary Syndrome; Severity of Illness Index; Triglycerides | 2002 |
Influence of low-dose oral contraception on peripheral blood lymphocyte subsets at particular phases of the hormonal cycle.
Topics: Adult; Antigens, CD; B-Lymphocytes; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Killer Cells, Natural; Lymphocyte Subsets; Lymphocytes, Null; Menstrual Cycle; Norgestrel; Prospective Studies; Reference Values | 2002 |
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia | 2002 |
[Ultrasonographic and lipid changes in polycystic ovary syndrome according to the type of treatment ].
Topics: Adult; Chlormadinone Acetate; Cholesterol; Desogestrel; Drug Therapy, Combination; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Ovarian Follicle; Polycystic Ovary Syndrome; Progesterone Congeners; Severity of Illness Index; Treatment Outcome; Triglycerides; Ultrasonography | 2002 |
Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Patient Compliance; Patient Satisfaction; Sensitivity and Specificity; Vagina; Vinyl Compounds | 2002 |
Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Placebos; Treatment Outcome; United States | 2002 |
Randomized controlled study of the influence of two low estrogen dose oral contraceptives containing gestodene or desogestrel on carbohydrate metabolism.
Topics: Adult; Blood Glucose; C-Peptide; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Norpregnenes; Uterine Hemorrhage | 2002 |
The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability.
Topics: Adolescent; Adult; Coitus; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Europe; Female; Humans; Male; North America; Patient Satisfaction; Surveys and Questionnaires; Vagina; Vinyl Compounds | 2003 |
Complete and robust ovulation inhibition with NuvaRing.
Topics: Biological Availability; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Ovulation Inhibition; Patient Compliance; Vinyl Compounds | 2002 |
The combined contraceptive ring NuvaRing and spermicide co-medication.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Interactions; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Nonoxynol; Spermatocidal Agents; Vinyl Compounds | 2003 |
Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Middle Aged; Severity of Illness Index; Sex Hormone-Binding Globulin; Treatment Outcome | 2003 |
A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome | 2003 |
A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolism.
Topics: Adolescent; Adult; Androstenes; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fasting; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Humans; Insulin; Kinetics | 2003 |
Estroprogestinic pill normalizes IGF-I levels in acromegalic women.
Topics: Acromegaly; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Pilot Projects; Progestins; Prospective Studies | 2003 |
Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Leptin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Steroids | 2003 |
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel.
Topics: Adult; Anthropometry; Blood Glucose; Body Weight; C-Peptide; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome | 2003 |
Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dysmenorrhea; Endometriosis; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Pain Measurement; Patient Satisfaction; Progesterone Congeners; Prospective Studies; Retreatment | 2003 |
Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Bupropion; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2B6; Desogestrel; Dopamine Uptake Inhibitors; Estradiol; Ethinyl Estradiol; Female; Half-Life; Hormone Replacement Therapy; Humans; Hydroxylation; Levonorgestrel; Metabolic Clearance Rate; Oxidoreductases, N-Demethylating | 2003 |
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Mutation; Protein C; Risk Factors; Thrombosis | 2004 |
Effect of a low-dose oral contraceptive containing 20 microg ethinylestradiol and 150 microg desogestrel on dysmenorrhea.
Topics: Activities of Daily Living; Adolescent; Adult; Analgesics; Contraceptives, Oral; Desogestrel; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Pain Measurement; Prospective Studies; Treatment Outcome | 2003 |
Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Hypericum; Ovary; Phytotherapy; Plant Extracts; Uterine Hemorrhage | 2003 |
Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 microg/ ethinylestradiol 15 microg and a 21-day regimen of desogestrel 150 microg/ethinylestradiol 20 microg.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Drug Administration Schedule; Estrogens; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 1999 |
A comparative study of the effects of gestodene 60 microg/ethinylestradiol 15 microg and desogestrel 150 microg/ethinylestradiol 20 microg on hemostatic balance, blood lipid levels and carbohydrate metabolism.
Topics: Adult; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Hemostasis; Humans; Lipids; Norpregnenes | 1999 |
The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; Miconazole | 2004 |
The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Administration Routes; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Tampons, Surgical | 2004 |
A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Topics: Adolescent; Adult; Androstenes; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies; Triglycerides | 2004 |
The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovarian Follicle | 2004 |
Effects of hormonal contraception on bone mineral density after 24 months of use.
Topics: Adolescent; Adult; Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Time Factors | 2004 |
Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Netherlands; Premenstrual Syndrome; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2004 |
Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hormones, Ectopic; Humans; Insulin; Middle Aged; Norpregnenes; Resistin; Treatment Outcome | 2004 |
[Effect of the monophase oral contraceptive combination with 20 ug ethinyl estradiol/150 ug desogestrel on haemostasis].
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Hemostasis; Humans | 2004 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Male; Patient Satisfaction; Prospective Studies; Sexual Behavior; Sexuality; Surveys and Questionnaires | 2005 |
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Topics: Adult; Appointments and Schedules; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Leuprolide; Ovarian Follicle; Pregnancy; Pregnancy Outcome; Prospective Studies | 2005 |
Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing with oral amoxicillin or doxycycline in two randomised trials.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Area Under Curve; Contraceptive Agents, Female; Cross-Over Studies; Delayed-Action Preparations; Desogestrel; Doxycycline; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans | 2005 |
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism.
Topics: Adult; Androstenes; Carbohydrate Metabolism; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Lipid Metabolism | 2005 |
The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.
Topics: Absorptiometry, Photon; Adolescent; Adult; Bone and Bones; Bone Density; Contraceptive Agents, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Premenopause; Time Factors | 2005 |
Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Body Mass Index; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Menstruation; Migraine Disorders; Neurosecretory Systems; Piperazines; Placebos; Prolactin; Serotonin; Serotonin Receptor Agonists; Time Factors | 2005 |
Extended regimens of the contraceptive vaginal ring: a randomized trial.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Pregnancy; Progesterone Congeners; Uterine Hemorrhage | 2005 |
Diagnosis and management of simple ovarian cysts.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Laparoscopy; Middle Aged; Ovarian Cysts; Treatment Outcome; Ultrasonography | 2005 |
Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive.
Topics: Administration, Intravaginal; Adolescent; Adult; Analysis of Variance; Body Mass Index; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Weight Gain | 2005 |
A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.
Topics: Adolescent; Adult; Cell Count; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Embryo, Mammalian; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormones; Humans; Luteinizing Hormone; Nafarelin; Oocytes; Ovarian Follicle; Ovulation Induction | 2006 |
A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Middle Aged; Mifepristone; Placebos | 2006 |
Comparison of uterine concentrations of ethinyl estradiol and etonogestrel after use of a contraceptive vaginal ring and an oral contraceptive.
Topics: Administration, Intravaginal; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Hysterectomy; Middle Aged; Progesterone Congeners; Tissue Distribution; Uterus | 2006 |
A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
Topics: Adolescent; Adult; Androstenes; Antithrombins; Coagulants; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Homeostasis; Humans; Prospective Studies; Protein C; Protein S | 2006 |
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Folic Acid; Homocysteine; Humans; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Vitamin B 12 | 2006 |
[Safety evaluation of a transdermal contraceptive system with an oral contraceptive].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Ethisterone; Female; Humans; Norgestrel; Oximes; Women's Health | 2005 |
Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone.
Topics: Administration, Oral; Adult; Androstenes; Body Composition; Body Weight; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Intrauterine Devices; Menstrual Cycle; Patient Compliance | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol.
Topics: Adult; Clinical Protocols; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Norethindrone; Ovarian Follicle; Ovary; Treatment Outcome; Ultrasonography | 2007 |
Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis.
Topics: Adult; Desogestrel; Endometriosis; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Pelvic Pain; Progestins; Weight Gain | 2007 |
Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
Topics: Adult; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hypolipidemic Agents; Pituitary Hormones; Polycystic Ovary Syndrome; Prospective Studies; Simvastatin; Testosterone; Treatment Outcome | 2007 |
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Adolescent; Adult; Androstenes; Contraception; Contraceptive Agents; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Patient Compliance; Patient Satisfaction; Pregnancy; Progesterone Congeners; Treatment Outcome | 2006 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
[Clinical study of two monophase oral contraceptives with desogestrel].
Topics: Blood Pressure; Body Mass Index; Body Weight; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies | 2007 |
Clinical experience with NuvaRing in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages.
Topics: Adolescent; Adult; Age Factors; Blood Pressure; Body Weight; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Patient Acceptance of Health Care; Pregnancy; Prospective Studies; Surveys and Questionnaires; Switzerland | 2007 |
Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids.
Topics: Administration, Intravaginal; Adult; Anti-Mullerian Hormone; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pancuronium | 2008 |
Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use.
Topics: Adolescent; Adult; Body Weight; Contraception; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Patient Satisfaction; Time Factors; Weight Gain | 2007 |
Use of the NuvaRing hormone-releasing system in late reproductive-age women with type 1 diabetes mellitus.
Topics: Adult; Aging; Blood Glucose; Carbohydrate Metabolism; Contraceptive Devices, Female; Desogestrel; Diabetes Mellitus, Type 1; Drug Combinations; Ethinyl Estradiol; Female; Glycated Hemoglobin; Hemostasis; Humans; Lipid Metabolism | 2008 |
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Middle Aged; Peptide Fragments; Prospective Studies; Protein Precursors; Prothrombin | 2008 |
Long-term safety and tolerability of flutamide for the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Hirsutism; Humans; Time Factors; Treatment Outcome; Young Adult | 2009 |
An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Middle Aged; Patient Compliance | 2008 |
Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo.
Topics: Adult; Contraceptives, Oral, Sequential; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Pregnancy; Treatment Outcome | 2008 |
Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Progestins | 2008 |
Sexual function in first-time contraceptive ring and contraceptive patch users.
Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Contraception; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Linear Models; Male; Patient Satisfaction; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Sexual Partners; Surveys and Questionnaires; Time Factors; United States; Young Adult | 2010 |
St John's wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive.
Topics: Administration, Oral; Adult; Area Under Curve; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Herb-Drug Interactions; Humans; Hypericum; Plant Extracts; Tablets | 2009 |
The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Topics: Adolescent; Adult; Apolipoproteins; Carbohydrate Metabolism; Chlormadinone Acetate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Lipid Metabolism; Lipids; Lipoproteins; Phospholipids; Single-Blind Method; Triglycerides; Young Adult | 2009 |
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Liver Function Tests; Luteinizing Hormone; Young Adult | 2009 |
Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis.
Topics: Administration, Cutaneous; Adolescent; Adult; Choice Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Norgestrel; Pain Measurement; Patient Satisfaction; Uterine Diseases; Young Adult | 2010 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Doxycycline; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Mifepristone; Uterine Hemorrhage | 2009 |
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperinsulinism; Prospective Studies; Young Adult | 2009 |
[Efficacy and safety of drospirenone-ethinylestradiol on contraception in healthy Chinese women: a multicenter randomized controlled trial].
Topics: Adult; Androstenes; Body Weight; China; Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstrual Cycle; Patient Satisfaction; Premenstrual Syndrome; Surveys and Questionnaires; Young Adult | 2009 |
Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Metrorrhagia; Patient Satisfaction; Treatment Outcome; Young Adult | 2009 |
Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
Topics: Absorptiometry, Photon; Amino Acids; Analysis of Variance; Bone and Bones; Bone Density; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Norgestrel; Oximes; Prospective Studies | 2010 |
Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Medication Adherence; Patient Satisfaction; Students; Universities; Young Adult | 2010 |
Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial.
Topics: Adult; Androstenes; Body Water; Body Weight; China; Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstrual Cycle | 2010 |
Effect on carbohydrate metabolism and analysis of acceptability (menstrual cycle control) of extended regimens of the vaginally inserted hormone-releasing system 'NuvaRing' as compared with the standard 21/7 regime in reproductive-age women with type 1 di
Topics: Administration, Intravaginal; Adult; Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Desogestrel; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Glycated Hemoglobin; Humans; Insulin; Intrauterine Devices, Medicated; Menstrual Cycle; Patient Acceptance of Health Care | 2010 |
An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Young Adult | 2010 |
Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Anthropometry; Blood Glucose; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Insulin; Lipoproteins, HDL; Lipoproteins, LDL; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric; Testosterone; Triglycerides; Young Adult | 2010 |
Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenedione; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Combined; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Statistics, Nonparametric; Testosterone; Young Adult | 2010 |
[Combined hormonal contraception in cycles artificially extended].
Topics: Administration, Cutaneous; Adolescent; Adult; Androstenes; Breast Diseases; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Headache; Humans; Menstrual Cycle; Norgestrel; Patient Acceptance of Health Care; Prospective Studies; Time Factors; Uterine Hemorrhage; Young Adult | 2010 |
Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Weight Gain; Young Adult | 2011 |
Combined oral contraceptive pills containing desogestrel or drospirenone enhance large vessel and microvasculature vasodilation in healthy premenopausal women.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Nitric Oxide Synthase Type III; Time Factors; Vasodilation | 2011 |
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.
Topics: Abortion, Spontaneous; Adult; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Ovulation Induction; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Progestins | 2011 |
Cycle control and bleeding pattern of a 24/4 regimen of drospirenone 3 mg/ethinylestradiol 20 μg compared with a 21/7 regimen of desogestrel 150 μg/ethinylestradiol 20 μg: a pooled analysis.
Topics: Adolescent; Adult; Androstenes; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation; Metrorrhagia; Young Adult | 2011 |
A randomized controlled trial of NuvaRing versus combined oral contraceptive pills for pretreatment in in vitro fertilization cycles.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Fertilization in Vitro; Humans; Infertility, Female; Ovarian Cysts; Ovary; Patient Satisfaction; Pregnancy; Pregnancy Rate; Young Adult | 2011 |
Contraceptive vaginal ring treatment of heavy menstrual bleeding: a randomized controlled trial with norethisterone.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menorrhagia; Norethindrone; Patient Satisfaction; Prospective Studies; Quality of Life; Young Adult | 2012 |
Effects of ethinyl estradiol and desogestrel on clinical and metabolic parameters in Indian patients with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adolescent; Adult; Blood Glucose; Body Composition; Body Mass Index; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Insulin; Insulin Resistance; Polycystic Ovary Syndrome; Progestins; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2012 |
A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Double-Blind Method; Drug Implants; Drug Interactions; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Humans; Luteinization; Menstrual Cycle; Middle Aged; Mifepristone; Ovary; Ovulation Inhibition; Ultrasonography; Uterine Hemorrhage; Viscosity; Young Adult | 2011 |
The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Peptide Hydrolases; Protein C; Protein C Inhibitor; Thrombophilia; Young Adult | 2012 |
Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Development; Bone and Bones; Bone Density; Bone Development; Bone Resorption; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Medication Adherence; Patient Dropouts | 2012 |
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Endometrium; Estrogens; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Menstruation; Obesity; Ovarian Follicle; Prospective Studies; Young Adult | 2012 |
Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
Topics: Adolescent; Adult; Biomarkers; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamo-Hypophyseal System; Inhibins; Luteinizing Hormone; Ovary; Prospective Studies; Young Adult | 2013 |
Efavirenz, in contrast to nevirapine, is associated with unfavorable progesterone and antiretroviral levels when coadministered with combined oral contraceptives.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptives, Oral, Synthetic; Cyclopropanes; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; HIV; HIV Infections; Humans; Logistic Models; Middle Aged; Nevirapine; Progesterone; Prospective Studies; Thailand; Young Adult | 2013 |
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route.
Topics: Administration, Cutaneous; Adult; Anti-Mullerian Hormone; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicle Stimulating Hormone, Human; Humans; Norgestrel; Ovarian Follicle; Oximes; Pituitary Gland; Prospective Studies; Young Adult | 2013 |
Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Obesity; Ovarian Follicle; Prospective Studies; Vagina; Young Adult | 2013 |
First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
Topics: Adult; Androstenedione; Contraceptives, Oral; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Embryo Transfer; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate; Prospective Studies; Recombinant Proteins; Testosterone; Treatment Outcome; Triptorelin Pamoate; Ultrasonography; Young Adult | 2013 |
Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative study.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Patient Satisfaction; Prospective Studies; Rectal Diseases | 2014 |
Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome.
Topics: Adolescent; Adult; Body Composition; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2014 |
Can extracorporeal magnetic innervation be a treatment modality for primary dysmenorrhea?
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Contraceptives, Oral, Hormonal; Desogestrel; Drug Administration Schedule; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Linear Models; Magnetic Field Therapy; Pain Measurement; Prospective Studies; Single-Blind Method; Treatment Outcome; Young Adult | 2014 |
Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome.
Topics: Abdominal Fat; Absorptiometry, Photon; Adiponectin; Adiposity; Adolescent; Adult; Body Mass Index; Chemokine CCL2; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Interleukin-6; Metformin; Obesity, Abdominal; Patient Dropouts; Polycystic Ovary Syndrome; Weight Gain; Whole Body Imaging; Young Adult | 2014 |
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Partial Thromboplastin Time; Prothrombin; Young Adult | 2014 |
Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Androstenedione; Cholesterol; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Lipoproteins, HDL; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Young Adult | 2015 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation Inhibition; Progesterone; Ultrasonography | 2015 |
Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.
Topics: Absorptiometry, Photon; Adolescent; Bone Density; Child; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lumbar Vertebrae; Young Adult | 2015 |
Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
Topics: Adolescent; Adult; C-Reactive Protein; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Metformin; Pilot Projects; Polycystic Ovary Syndrome; Thrombin; Up-Regulation; Young Adult | 2015 |
Comparison of combined hormonal vaginal ring with ultralow-dose combined oral contraceptive pills in the management of heavy menstrual bleeding: A pilot study.
Topics: Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menorrhagia; Pilot Projects | 2016 |
Efficacy and safety of a 21/7-active combined oral contraceptive with continuous low-dose ethinyl estradiol.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Pregnancy; Pregnancy Rate; Young Adult | 2016 |
High Variability of Hormonal Levels and No Clinically Relevant Interaction Between Ethinyl Estradiol, Desogestrel and Lopinavir/Ritonavir in a Small Sample of HIV-positive Adolescents.
Topics: Adolescent; Anti-HIV Agents; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Drug Interactions; Ethinyl Estradiol; HIV Infections; Humans; Lopinavir; Pilot Projects; Prospective Studies; Ritonavir; Treatment Outcome | 2016 |
Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Cross-Over Studies; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Fingers; Humans; Middle Aged; Surveys and Questionnaires; Vagina; Young Adult | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study.
Topics: Adult; Antithrombins; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Humans; Partial Thromboplastin Time; Peptide Fragments; Protein C; Protein S; Prothrombin; Young Adult | 2016 |
Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial.
Topics: Adolescent; Adult; China; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Medication Adherence; Metrorrhagia; Young Adult | 2016 |
Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma.
Topics: Adult; Benzopyrans; Contraceptives, Oral; Desogestrel; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Humans; Leiomyoma; Middle Aged; Treatment Outcome; Uterine Hemorrhage | 2016 |
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial.
Topics: Adult; Cognitive Dysfunction; Desogestrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Interferon beta-1a; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting; Quality of Life; Time Factors; Treatment Outcome; Young Adult | 2017 |
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Topics: Adult; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Blood Glucose; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; Pharmacogenetics; Pharmacogenomic Variants; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Triglycerides; Weight Loss; Young Adult | 2018 |
A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.
Topics: Adult; Contraception; Contraceptive Agents; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; HIV Infections; Humans; Pregnancy; Rwanda; Vagina | 2018 |
Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Drug Monitoring; Estradiol; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Outcome Assessment, Health Care; Ovulation Inhibition | 2018 |
Oestrogen replacement improves bone mineral density in oligo-amenorrhoeic athletes: a randomised clinical trial.
Topics: Absorptiometry, Photon; Administration, Oral; Adolescent; Adult; Amenorrhea; Athletes; Bone Density; Desogestrel; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Transdermal Patch; Young Adult | 2019 |
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
Topics: Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Cyclopropanes; Cytochrome P-450 CYP2B6; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Genetic Association Studies; Genotype; HIV Infections; Humans; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Ritonavir; Vagina | 2020 |
Letrozole combined with oral contraceptives versus oral contraceptives alone in the treatment of endometriosis-related pain symptoms: a pilot study.
Topics: Adult; Aromatase Inhibitors; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Endometriosis; Ethinyl Estradiol; Female; Humans; Letrozole; Pain; Pilot Projects; Young Adult | 2021 |
Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators.
Topics: Adult; Antigens, Differentiation, T-Lymphocyte; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Immunity, Mucosal; Menstrual Cycle; Middle Aged | 2021 |
Effect of two combinations of low-dose oral contraceptives on adolescent bone mass: A clinical trial with 2 years follow-up.
Topics: Adolescent; Alkaline Phosphatase; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Osteocalcin | 2022 |
Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.
Topics: Contraceptive Devices; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans | 2023 |
267 other study(ies) available for ethinyl estradiol and desogestrel
Article | Year |
---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of oral contraceptive containing a new progestin (ORG 2969) on plasma renin activity, growth hormone and immunoreactive insulin.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Insulin; Menstruation; Norpregnenes; Progesterone Congeners; Renin | 1979 |
Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel.
Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Kinetics; Luteinizing Hormone; Sex Hormone-Binding Globulin; Transcortin | 1992 |
Increased capillary permeability for plasma proteins in oral contraceptive users.
Topics: Adolescent; Adult; Biological Transport; Blood Proteins; Capillary Permeability; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Hemoglobins; Humans; Norpregnenes; Osmosis; Serum Albumin | 1992 |
Oral contraception affects osteocalcin serum profiles in young women.
Topics: Adult; Circadian Rhythm; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osmolar Concentration; Osteocalcin | 1992 |
Ovarian activity and bleeding patterns during extended continuous use of a combined contraceptive vaginal ring.
Topics: Administration, Intravaginal; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Endometrium; Estradiol; Ethinyl Estradiol; Female; Hemorrhage; Humans; Ovulation; Progesterone Congeners; Silicone Elastomers; Time Factors | 1992 |
Influence of oral contraceptive agents on kidney function and protein metabolism.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Dietary Proteins; Drug Combinations; Ethinyl Estradiol; Female; Germany; Glomerular Filtration Rate; Humans; Kidney; Norpregnenes | 1992 |
The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora.
Topics: Administration, Intravaginal; Animals; Chlamydia trachomatis; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Norpregnenes; Saccharomyces cerevisiae; Time Factors; Trichomonas vaginalis; Vagina | 1992 |
Deep vein thrombophlebitis of a leg in a young female with heterozygous protein C deficiency taking oral contraceptives.
Topics: Adult; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Heterozygote; Humans; Male; Norpregnenes; Progesterone Congeners; Protein C Deficiency; Thrombophlebitis | 1990 |
Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1991 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |
[Were the severe adverse effects on several organs and the marked blood pressure increase caused by oral contraceptives?].
Topics: Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hypertension; Liver; Musculoskeletal System; Norpregnenes; Progestins | 1991 |
[Clinical experience with Mercilon and Marvelon with special reference to ovarian function].
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norpregnenes; Ovulation; Progesterone Congeners | 1991 |
Postponement of withdrawal bleeding with a monophasic oral contraceptive containing desogestrel and ethinylestradiol.
Topics: Adolescent; Adult; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes; Patient Acceptance of Health Care; Progesterone Congeners; Time Factors | 1991 |
Low estrogen oral contraceptives and the hypothalamo-pituitary axis.
Topics: Adolescent; Adult; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Norpregnenes; Progesterone Congeners; Prolactin; Thyrotropin | 1991 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design.
Topics: Adult; Biological Availability; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Norpregnenes | 1991 |
Metabolism of the contraceptive steroid desogestrel by human liver in vitro.
Topics: Adolescent; Adult; Aged; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Desogestrel; Dihydrotestosterone; Ethinyl Estradiol; Female; Humans; In Vitro Techniques; Male; Miconazole; Microsomes, Liver; Middle Aged; Norpregnenes; Oxidative Phosphorylation Coupling Factors; Primaquine; Progesterone Congeners | 1990 |
Time-dependent alterations in lipid metabolism during treatment with low-dose oral contraceptives.
Topics: Adolescent; Adult; Arteriosclerosis; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Progesterone Congeners; Reference Values; Risk Factors; Time Factors | 1990 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1990 |
Hemostasis profile in women taking low-dose oral contraceptives.
Topics: Adult; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Norgestrel; Norpregnenes; Progesterone Congeners; Reference Values; Serum Globulins | 1990 |
Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Norpregnenes; Sex Hormone-Binding Globulin; Time Factors; Transcortin | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low dose oral contraceptive in premenopausal middle-aged women.
Topics: Adult; Antithrombin III; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Hemostasis; Humans; Lipoproteins; Lipoproteins, LDL; Norgestrel; Norpregnenes; Protein C; Triglycerides | 1990 |
Altered growth hormone secretion during oral contraception.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pituitary Gland, Anterior; Progesterone Congeners | 1990 |
Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings.
Topics: Administration, Oral; Adult; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Injections, Intravenous; Metabolic Clearance Rate; Norpregnenes; Progesterone Congeners; Radioimmunoassay | 1990 |
Contraception with a vaginal ring releasing 3-keto desogestrel and ethinylestradiol.
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Humans; Menstruation; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin | 1990 |
Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
Topics: Blood Proteins; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Protein Binding; Radioimmunoassay | 1990 |
Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa.
Topics: Chromatography, High Pressure Liquid; Desogestrel; Ethinyl Estradiol; Humans; Intestinal Mucosa; Norpregnenes | 1989 |
Interaction with the pharmacokinetics of ethinylestradiol and progestogens contained in oral contraceptives.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progestins; Transcortin | 1989 |
Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive.
Topics: Adult; Age Factors; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pregnancy; Progesterone Congeners; Substance Withdrawal Syndrome | 1989 |
Pituitary-ovarian activity when switching from various monophasic pills to a triphasic pill.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Norethindrone; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Pituitary Gland; Progesterone; Progestins | 1989 |
Clinical evaluation of a new combined oral contraceptive desogestrel--ethinylestradiol.
Topics: Adolescent; Adult; Blood Pressure; Body Weight; Cervix Mucus; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Libido; Lipoproteins; Menstrual Cycle; Menstruation; Norpregnenes; Triglycerides; Vagina | 1989 |
[Understanding microcapillary angioma, observations in pregnant patients and in females treated with hormonal contraceptives].
Topics: Capillaries; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Hemangioma; Humans; Neoplasms, Hormone-Dependent; Norpregnenes; Pregnancy; Pregnancy Complications, Neoplastic; Skin; Skin Neoplasms | 1989 |
Mercilon--a new low-dose combined oral contraceptive.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Pancuronium; Progesterone Congeners | 1989 |
The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hair; Hirsutism; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone | 1986 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance.
Topics: Adult; Blood Glucose; Contraceptives, Oral; Desogestrel; Drug Evaluation; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Gastrins; Growth Hormone; Humans; Norgestrel; Norpregnenes; Random Allocation; Thyroid Gland; Thyroid Hormones | 1985 |
Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1986 |
Oral contraceptives and blood coagulation.
Topics: Age Factors; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Factor VII; Factor X; Female; Fibrinolysis; Humans; Norgestrel; Norpregnenes; Platelet Aggregation; Prothrombin; Thromboembolism | 1986 |
Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel.
Topics: Administration, Oral; Biotransformation; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1986 |
Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins A; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins; Lipoproteins, VLDL; Norpregnenes | 1986 |
Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1987 |
[Laboratory and clinical study with a new progestagen combined with ethinyl estradiol used in contraception].
Topics: Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Pregnancy; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Biliary lipids, bile acid metabolism, gallbladder motor function and small intestinal transit during ingestion of a sub-fifty oral contraceptive.
Topics: Adult; Bile; Bile Acids and Salts; Cholelithiasis; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder; Humans; Intestine, Small; Kinetics; Lactulose; Lipids; Norpregnenes | 1987 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |
Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Insulin; Lipids; Menstrual Cycle; Norpregnenes; Time Factors | 1987 |
Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
Topics: Adolescent; Androgens; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Menstruation Disturbances; Norpregnenes; Oligomenorrhea; Polycystic Ovary Syndrome | 1987 |
Effects of combined desogestrel-ethinylestradiol treatment on lipid profiles in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Luteinizing Hormone; Norpregnenes; Polycystic Ovary Syndrome; Testosterone; Triglycerides | 1987 |
Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel.
Topics: Administration, Oral; Adult; Biological Availability; Desogestrel; Ethinyl Estradiol; Female; Humans; Injections, Intravenous; Kinetics; Norpregnenes | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Chorea induced by the use of oral contraceptives. Report of a case and review of the literature.
Topics: Adult; Chorea; Contraceptives, Oral, Combined; Corpus Striatum; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Receptors, Dopamine | 1987 |
[Side effects of hormonal contraception. Experiences with 1,702 patients and 17,228 cycles].
Topics: Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes | 1987 |
A new oral contraceptive, Femovan.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes | 1987 |
Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.
Topics: Adult; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hormones; Humans; Longitudinal Studies; Menstruation Disturbances; Norpregnenes; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1987 |
A new low-dose estrogen oral contraceptive combination: effect on endocrine parameters and lipid status.
Topics: Adult; Apoproteins; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Hormones; Humans; Lipids; Lipoproteins; Norpregnenes; Sex Hormone-Binding Globulin; Triglycerides | 1987 |
Trace elements during 2 years' oral contraception with low-estrogen preparations.
Topics: Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Levonorgestrel; Norgestrel; Norpregnenes; Trace Elements; Zinc | 1988 |
Progestagen-dependent effect on some plasma proteins during oral contraception.
Topics: Blood Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Sex Hormone-Binding Globulin; Transcortin | 1988 |
[The combined effect of an ethinylestradiol/desogestrel contraceptive combination on blood lipids and parameters of liver function and coagulation].
Topics: Adolescent; Adult; Blood Coagulation; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Liver; Norpregnenes; Progesterone Congeners | 1988 |
[Postcoital contraception using a desogestrel-ethinyl estradiol combination].
Topics: Adolescent; Adult; Contraceptives, Postcoital; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1988 |
Advantage of desogestrel containing pill in oral contraception: influence on blood lipids and LCAT activity.
Topics: Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Phosphatidylcholine-Sterol O-Acyltransferase | 1987 |
Serum levels of 3-keto-desogestrel and SHBG during 12 cycles of treatment with 30 micrograms ethinylestradiol and 150 micrograms desogestrel.
Topics: Adult; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Sex Hormone-Binding Globulin; Time Factors | 1988 |
Comparative trial of the effects on glucose tolerance and lipoprotein metabolism of two new oral contraceptives containing gestoden and desogestrel.
Topics: Adult; Blood Glucose; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Lipoproteins; Norpregnenes | 1988 |
Clinical evaluation of a monophasic ethinylestradiol/desogestrel-containing oral contraceptive.
Topics: Adult; Blood Pressure; Body Weight; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Norpregnenes; Progesterone Congeners | 1988 |
[Effects of the oral administration of a contraceptive on lipid balance and on the concentration of serum tocopherol].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Progesterone Congeners; Vitamin E | 1988 |
[Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].
Topics: Adolescent; Adult; Androgens; Androstenedione; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydroxyprogesterones; Norpregnenes; Polycystic Ovary Syndrome; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol.
Topics: Adolescent; Adult; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hair; Hirsutism; Humans; Methods; Norpregnenes; Progesterone Congeners | 1985 |
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Topics: Adult; Castration; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norgestrel; Norpregnenes | 1985 |
Pharmacodynamic studies on desogestrel administered alone and in combination with ethinylestradiol.
Topics: Adolescent; Adult; Androgens; Blood Proteins; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Hirsutism; Humans; Libido; Lipids; Norpregnenes; Ovary; Pituitary Gland; Polycystic Ovary Syndrome; Progestins; Sex Hormone-Binding Globulin; Vagina | 1985 |
A multi-compartment vaginal ring system for independently adjustable release of contraceptive steroids.
Topics: Administration, Intravaginal; Administration, Topical; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Contraceptive Devices; Desogestrel; Equipment Design; Ethinyl Estradiol; In Vitro Techniques; Norpregnenes; Steroids | 1986 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Metyrapone; Norgestrel; Norpregnenes; Progestins; Random Allocation | 1982 |
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Random Allocation; Serum Globulins; Sex Hormone-Binding Globulin; Transcortin | 1983 |
Synthesis and release of gonadotropins: effect of an oral contraceptive.
Topics: Adolescent; Adult; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norpregnenes; Pituitary Hormone-Releasing Hormones; Time Factors | 1983 |
Thyroid function during treatment with a new oral contraceptive combination containing desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Thyroid Gland; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1983 |
Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel.
Topics: Adult; Blood Proteins; Carrier Proteins; Ceruloplasmin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Norpregnenes; Pregnancy; Sex Hormone-Binding Globulin; Thyroxine-Binding Proteins; Triglycerides | 1983 |
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1984 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Marvelon--an OC with a new progestagen.
Topics: Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progesterone Congeners | 1984 |
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Castration; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Phosphatidylcholines; Progesterone Congeners; Stereoisomerism; Uterine Cervical Neoplasms | 1984 |
Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Menstrual Cycle; Norpregnenes; Radioimmunoassay | 1984 |
Short-term effects of desogestrel and ethinyloestradiol on serum proteins in women.
Topics: Adult; Blood Proteins; Ceruloplasmin; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Haptoglobins; Humans; Norpregnenes; Sex Hormone-Binding Globulin; Transcortin | 1984 |
[Comparison of a 2-phase preparation (Oviol 22) with a low-dose 1-phase preparation (Ovoresta M)].
Topics: Adult; Body Weight; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lynestrenol; Menstrual Cycle; Norpregnenes | 1984 |
[A combiphasic oral contraceptive containing ethinylestradiol and desogestrel].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans | 1995 |
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors | 1995 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Middle Aged; Mutation; Progestins; Risk Factors; Thrombophlebitis | 1995 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
Topics: Adult; Aminolevulinic Acid; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Coproporphyrins; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Porphobilinogen; Porphyrias; Porphyrias, Hepatic; Porphyrins; Uroporphyrins | 1995 |
Bone mineral density in young women with long-standing amenorrhea: limited effect of hormone replacement therapy with ethinylestradiol and desogestrel.
Topics: Adult; Amenorrhea; Bone Density; Desogestrel; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Osteoporosis; Time Factors | 1994 |
Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Sex Hormone-Binding Globulin | 1994 |
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.
Topics: Acne Vulgaris; Adolescent; Adult; Apolipoproteins A; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Hyperandrogenism; Sex Hormone-Binding Globulin | 1994 |
Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
Topics: Apolipoprotein A-I; Apolipoprotein A-II; Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, VLDL; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipids; Triglycerides | 1993 |
Evaluation of risk of thrombosis during use of low-dose ethinylestradiol-desogestrel oral contraceptive.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Antithrombin III; Apolipoproteins A; Apolipoproteins B; Blood Coagulation Tests; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Plasminogen; Protein C; Risk Factors; Thrombosis; Triglycerides | 1993 |
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
Topics: Adolescent; Adult; Blood; Contraceptives, Oral; Cross-Sectional Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lipoproteins, HDL; Norpregnenes; Progestins | 1993 |
Effects of an oral contraceptive combination containing 0.150 mg desogestrel plus 0.020 mg ethinyl estradiol on healthy premenopausal women.
Topics: Blood Coagulation Tests; Bone Density; Climacteric; Contraceptives, Oral, Combined; Desogestrel; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Lipids; Middle Aged | 1993 |
Antioxidant erythrocyte enzyme activities during oral contraception.
Topics: Adolescent; Adult; Antioxidants; Catalase; Contraceptives, Oral; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Glutathione Peroxidase; Humans; Pyruvate Kinase; Superoxide Dismutase | 1993 |
Desogestrel--a new progestin for oral contraception.
Topics: Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1993 |
The effect of a biphasic desogestrel-containing oral contraceptive on carbohydrate metabolism and various hormonal parameters.
Topics: Adult; Blood Glucose; Carbohydrates; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Insulin; Prolactin; Sex Hormone-Binding Globulin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1993 |
Effect on lipid metabolism of a biphasic desogestrel-containing oral contraceptive: divergent changes in apolipoprotein B and E and transitory decrease in Lp(a) levels.
Topics: Adult; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipoprotein(a); Triglycerides | 1993 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neoplasms; Endometrium; Estradiol; Estrone; Ethinyl Estradiol; Female; Humans; Kinetics; Norgestrel; Tumor Cells, Cultured | 1993 |
[Metabolic effects of oral contraceptives].
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose; Hemostasis; Humans; Lipid Metabolism; Norpregnenes | 1993 |
[The desogestrel-ethinyl estradiol combination and overweight: current data].
Topics: Adolescent; Adult; Body Weight; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Obesity; Progesterone Congeners; Time Factors | 1995 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
[Oral hormonal contraception: more or less estrogens?].
Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans | 1995 |
[Hemodynamics and ergometric performance modified by low dosage oral contraceptives].
Topics: Adult; Blood Pressure; Child, Preschool; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Exercise Test; Female; Heart Rate; Humans; Menstrual Cycle | 1996 |
Third-generation oral contraceptives and low free protein S as a risk for venous thrombosis.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Femoral Vein; Humans; Popliteal Vein; Protein S Deficiency; Risk Factors; Thrombosis | 1996 |
The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
Topics: Adult; Antithrombin III; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor VII; Factor X; Female; Fibrinogen; Hemostasis; Humans; Norpregnenes; Plasminogen; Plasminogen Activator Inhibitor 1; Progestins; Protein C; Tissue Plasminogen Activator | 1996 |
Ureteral obstruction due to retroperitoneal endometriosis: a conservative approach including surgery and GnRH analogs.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hydronephrosis; Hypertension, Renal; Leuprolide; Retroperitoneal Space; Ureteral Obstruction | 1996 |
Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
Topics: Adult; Amino Acids; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle | 1996 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Topics: Adolescent; Adult; Case-Control Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Population Surveillance; Progesterone Congeners; Risk Factors; Thromboembolism; Thrombophlebitis; United Kingdom | 1997 |
[Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].
Topics: Adult; Angiography; Contraceptives, Oral, Synthetic; Coronary Thrombosis; Desogestrel; Diagnosis, Differential; Echocardiography, Transesophageal; Ethinyl Estradiol; Female; Heart Septal Defects, Atrial; Humans; Pulmonary Embolism; Risk Factors; Thromboembolism; Thrombosis; Ulnar Artery | 1997 |
Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin. UK Desogen Study Group.
Topics: Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Desogestrel; Endocrine Glands; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Lipids; Lipoproteins; Luteinizing Hormone; Progesterone; Thyroxine; Triglycerides; Triiodothyronine | 1997 |
Effects of menstrual cycle on creativity.
Topics: Adult; Contraceptives, Oral, Combined; Creativity; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Luteinizing Hormone; Menstrual Cycle; Norpregnenes; Personality Inventory | 1994 |
The effect of oral contraceptive agents on the basal metabolic rate of young women.
Topics: Adult; Anthropometry; Basal Metabolism; Blood Pressure; Body Composition; Calorimetry, Indirect; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Pulse; Stimulation, Chemical; Systole | 1997 |
The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Austria; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; France; Germany; Humans; Myocardial Infarction; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Smoking; Switzerland; United Kingdom | 1997 |
First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Austria; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; France; Germany; Humans; Logistic Models; Norpregnenes; Progesterone Congeners; Pulmonary Embolism; Risk Factors; Switzerland; Thrombophlebitis; United Kingdom; Veins | 1997 |
Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Clomiphene; Desogestrel; Embryo Transfer; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Humans; Infertility; Menotropins; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1997 |
[Endocrinologic and metabolic complications of Alagille syndrome].
Topics: Adult; Alagille Syndrome; Cholestasis, Intrahepatic; Contraceptives, Oral, Hormonal; Desogestrel; Dwarfism, Pituitary; Ethinyl Estradiol; Female; Humans; Rickets; Spinocerebellar Degenerations; Vitamin D Deficiency | 1997 |
Marked gender differences in ambulatory morning growth hormone values in young adults.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Fasting; Female; Human Growth Hormone; Humans; Levonorgestrel; Male; Prospective Studies; Sex Factors | 1998 |
Mircette: a novel oral contraceptive. Introduction.
Topics: Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1998 |
Effects on bone mass of two oral contraceptives containing ethinylestradiol and cyproterone acetate or desogestrel: results of a 2-year follow-up.
Topics: Adult; Bone Density; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Progesterone Congeners | 1998 |
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
Topics: Adult; Buserelin; Case-Control Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Premedication; Progesterone Congeners; Retrospective Studies; Secretory Rate | 1998 |
Serum leptin concentrations in women taking oral contraceptives.
Topics: Adipose Tissue; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Energy Metabolism; Ethinyl Estradiol; Female; Humans; Leptin; Proteins | 1999 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Topics: Adult; Androgens; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Electrocoagulation; Estrogens; Ethinyl Estradiol; Female; Gonadotropins; Humans; Hyperandrogenism; Infertility, Female; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1999 |
Endometrial histology during use of a low-dose estrogen-desogestrel oral contraceptive with a reduced hormone-free interval.
Topics: Adult; Biopsy; Contraceptives, Oral, Combined; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Menstrual Cycle | 1999 |
[Recurrent bleeding of thalamic cavernous angioma under hormonal treatment. A case report].
Topics: Acne Vulgaris; Adult; Brain Neoplasms; Cerebral Arteries; Cerebral Hemorrhage; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Dydrogesterone; Ethinyl Estradiol; Female; Headache; Hemangioma, Cavernous; Hematoma; Hemiplegia; Humans; Magnetic Resonance Imaging; Megestrol; Menstruation Disturbances; Metrorrhagia; Paresthesia; Progesterone Congeners; Thalamus | 1999 |
[Changes in the concentration of individual proteins in women using current peroral contraceptives].
Topics: Adolescent; Adult; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Induction of estrogen receptor-alpha and -beta activities by synthetic progestins.
Topics: Animals; COS Cells; Desogestrel; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Ethinyl Estradiol; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Norethindrone; Norethynodrel; Progesterone Congeners; Receptors, Estrogen; Transfection | 2000 |
Oral contraceptives.
Topics: Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Depression; Desogestrel; Drug Interactions; Estrogens; Ethinyl Estradiol; Female; Humans; Nausea; Progesterone Congeners; Progestins; Venous Thrombosis; Weight Gain | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium.
Topics: Cell Count; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Endometrium; Endothelial Growth Factors; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Immunohistochemistry; Lymphokines; Menstrual Cycle; Progesterone Congeners; Progestins; Receptors, Estrogen; Receptors, Progesterone; Uterine Hemorrhage; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vinyl Compounds | 2000 |
Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.
Topics: Cervix Uteri; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Patient Compliance; Vinyl Compounds | 2001 |
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein S; Risk; Venous Thrombosis | 2001 |
Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Reference Values | 2001 |
A prospective study evidencing rhinomanometric and olfactometric outcomes in women taking oral contraceptives.
Topics: Adolescent; Adult; Ammonia; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Follicular Phase; Humans; Luteal Phase; Male; Menstrual Cycle; Norpregnenes; Odorants; Ovulation; Pimpinella; Prospective Studies; Pyridines; Rhinomanometry; Smell; Syzygium | 2001 |
Medical management of dysfunctional uterine bleeding.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Menorrhagia; Prospective Studies | 2001 |
Oral contraceptives and the risk of myocardial infarction.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking | 2001 |
In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring.
Topics: Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Interactions; Ethinyl Estradiol; Solubility; Time Factors; Vinyl Compounds | 2002 |
Prothrombotic effects and clinical implications of third-generation oral contraceptives use.
Topics: Adult; Antithrombin III; Blood Coagulation Tests; Contraceptives, Oral, Synthetic; Desogestrel; Drug Evaluation; Ethinyl Estradiol; Female; Hemostasis; Humans; Norpregnenes; Protein C; Protein S; Reference Values; Thrombophilia | 2002 |
[Low-dose combination oral contraceptives use in women with uterine leiomyomas].
Topics: Adult; Chi-Square Distribution; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Data Interpretation, Statistical; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Follow-Up Studies; Hematocrit; Humans; Leiomyoma; Menstruation; Middle Aged; Norpregnenes; Progesterone Congeners; Prospective Studies; Time Factors; Ultrasonography; Uterine Neoplasms; Uterus | 2002 |
Effects of a monophasic pill containing 20 microg ethinylestradiol and 150 microg desogestrel on lipid metabolism in Thai women.
Topics: Adolescent; Adult; Apolipoproteins B; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Prospective Studies; Sampling Studies; Sensitivity and Specificity; Thailand; Triglycerides | 2002 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
[Vaginal contraception with steroids].
Topics: Biology; Clinical Trials as Topic; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; France; Metabolism; Ovulation; Physiology; Research | 1993 |
Duramed Pharmaceuticals targets women's health.
Topics: Americas; Biology; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Desogestrel; Developed Countries; Endocrine System; Estrogens; Ethinyl Estradiol; Family Planning Services; Government Agencies; Hormones; Legislation as Topic; North America; Organizations; Physiology; United States; United States Food and Drug Administration; United States Public Health Service | 2000 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
[The latest progestagens].
Topics: Biology; Blood; Blood Coagulation; Cardiovascular System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; Lipids; Membrane Proteins; Physiology | 1993 |
[Side effects of third generation progestagens].
Topics: Biology; Blood; Blood Coagulation; Cardiovascular System; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Developed Countries; Ethinyl Estradiol; Europe; Family Planning Services; Lipids; Membrane Proteins; Physiology | 1993 |
A prospective study of a monophasic oral contraceptive containing 30 mcg ethinyl oestradiol and 150 mcg desogestrel (Marvelon).
Topics: Acne Vulgaris; Asia; Asia, Southeastern; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Dermatitis; Desogestrel; Developing Countries; Disease; Ethinyl Estradiol; Family Planning Services; Health Planning; Malaysia; Menstruation Disturbances; Prospective Studies; Research | 1994 |
Coagulation profile in women on low-dose oral contraceptive pills.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Desogestrel; Developing Countries; Ethinyl Estradiol; Family Planning Services; Human Experimentation; Levonorgestrel; Malaysia; Physiology; Research | 1990 |
Auditory brainstem response in premenopausal women taking oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Evoked Potentials, Auditory, Brain Stem; Female; Follicular Phase; Humans; Luteal Phase; Norpregnenes; Premenopause; Prospective Studies; Reaction Time | 2003 |
Introduction. NuvaRing.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Vinyl Compounds | 2002 |
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Levonorgestrel; Norpregnenes; Progestins; Rabbits | 2003 |
[Practical use of desogen, general considerations and therapeutical comments].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Desogestrel; Drug Combinations; Ethinyl Estradiol; Quaternary Ammonium Compounds | 1952 |
[Value of disinfecting desogen coating against germ transmission by hands].
Topics: Anti-Infective Agents, Local; Desogestrel; Disinfectants; Disinfection; Drug Combinations; Ethinyl Estradiol; Hand; Humans; Sterilization | 1953 |
Trypsin-desogen treatment of sputum for isolation of tubercle bacilli.
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Bacillus; Bacteriology; Desogestrel; Drug Combinations; Ethinyl Estradiol; Gram-Positive Bacteria; Humans; Lacticaseibacillus casei; Mycobacterium tuberculosis; Quaternary Ammonium Compounds; Sputum; Trypsin | 1956 |
[Prevention of gonorrheal ophthalmia in the newborn; desogen as a new prophylactic].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Desogestrel; Drug Combinations; Endophthalmitis; Ethinyl Estradiol; Gonorrhea; Humans; Infant, Newborn; Ophthalmia Neonatorum; Quaternary Ammonium Compounds | 1957 |
[Credé's method of prevention of blennorrhea neonatorum; its evolution; need of current methods; prevention with desogen].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Coloring Agents; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Infant, Newborn; Ophthalmia Neonatorum; Penicillins; Quaternary Ammonium Compounds; Silver Nitrate | 1957 |
[A new method of preventing blenorrhea neonatorum with desogen (Geigy)].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Biomedical Research; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Infant, Newborn; Ophthalmia Neonatorum; Quaternary Ammonium Compounds | 1957 |
[Effect of desogen on Trichomonas vaginalis].
Topics: Ammonium Compounds; Anti-Infective Agents, Local; Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans; Quaternary Ammonium Compounds; Trichomonas; Trichomonas vaginalis | 1958 |
Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Russia; Severity of Illness Index; Treatment Outcome | 2003 |
[Clinical study of the low dose oral contraceptive novynette].
Topics: Contraceptives, Oral, Combined; Desogestrel; Drug Evaluation; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Prospective Studies | 2003 |
[Vaginal contraception: new form of administration of hormonal contraception].
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pregnancy | 2003 |
[Effect of low-dose oral contraceptive regulon-Gedeon Richter on some hemostatic variables].
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Prospective Studies; Time Factors | 2004 |
Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Androstenedione; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Insulin; Luteinizing Hormone; Polycystic Ovary Syndrome; Prostate-Specific Antigen; Testosterone | 2004 |
Combined administration of low-dose gossypol acetic acid with desogestrel/mini-dose ethinylestradiol/testosterone undecanoate as an oral contraceptive for men.
Topics: Animals; Body Weight; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Fertility; Gossypol; Male; Organ Size; Random Allocation; Rats; Rats, Wistar; Sexual Behavior, Animal; Sperm Motility; Spermatogenesis; Testis; Testosterone | 2004 |
Spontaneous dissection of carotid and coronary arteries.
Topics: Adult; Aortic Dissection; Carotid Artery, Internal, Dissection; Cell Lineage; Collagen; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Coronary Aneurysm; Coronary Angiography; Desogestrel; Ethinyl Estradiol; Extracellular Matrix; Female; Humans; Myocardial Infarction; Neural Crest; Tomography, Spiral Computed; Tunica Media | 2004 |
[Novynette--trends in contraception at the beginning of the new millennium].
Topics: Contraception; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans | 2004 |
Effect of oral contraceptive treatment on bone mass acquisition in skeletally immature young female rats.
Topics: Absorptiometry, Photon; Algorithms; Animal Nutritional Physiological Phenomena; Animals; Anthropometry; Biomarkers; Bone Density; Bone Development; Calcium; Contraceptives, Oral; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Osteocalcin; Rats; Rats, Wistar; Time Factors | 2005 |
The combined contraceptive vaginal ring (NuvaRing): first experience in daily clinical practice in The Netherlands.
Topics: Adolescent; Adult; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Netherlands; Patient Compliance; Patient Satisfaction | 2006 |
Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Treatment Outcome | 2006 |
Exercise-induced fibrin formation is enhanced in women using third-generation oral contraceptives.
Topics: Adult; Blood Coagulation; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Exercise; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Humans; Protein C; Pulmonary Embolism | 2006 |
[The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
Topics: Acute-Phase Proteins; Adolescent; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Time Factors | 2006 |
Contraception: an international perspective.
Topics: Contraception; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Administration Routes; Ethinyl Estradiol; Female; Humans; Internationality | 2006 |
Bleeding patterns of women using extended regimens of the contraceptive vaginal ring.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Menstruation Disturbances; Prospective Studies | 2007 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
Topics: Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Randomized Controlled Trials as Topic; Research Design | 2007 |
Clinical inquiries. What hormonal contraception is most effective for obese women?
Topics: Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Evidence-Based Medicine; Female; Humans; Medroxyprogesterone Acetate; Norgestrel; Obesity; Pregnancy; Pregnancy Rate; Risk Assessment | 2007 |
Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue.
Topics: Cell Line, Tumor; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Humans; Levonorgestrel; Placenta; Receptors, LDL; Up-Regulation | 2007 |
Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR).
Topics: Biofilms; Candida; Candidiasis, Vulvovaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Saccharomyces cerevisiae | 2007 |
Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient.
Topics: Adult; Apolipoprotein A-V; Apolipoproteins A; Desogestrel; Ethinyl Estradiol; Female; Humans; Hypertriglyceridemia | 2008 |
About the importance of the resistance determination of cystitis pathogens in vitro for the therapy with Elkosin, Penicillin and Desogen.
Topics: Desogestrel; Drug Combinations; Ethinyl Estradiol; Penicillin Resistance; Penicillins; Sulfisomidine; Urinary Tract | 1948 |
[Nuvaring is a novel contraception method].
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2007 |
Interference in urinary free cortisol determination by components of the NuvaRing contraceptive device.
Topics: Adult; Artifacts; Cross Reactions; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Immunoassay; Pregnancy; Urine | 2008 |
Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.
Topics: Animals; Chorionic Gonadotropin; Clomiphene; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Luteinizing Hormone; Menstrual Cycle; Oocyte Retrieval; Ovulation; Ovulation Induction; Papio anubis; Pregnancy; Progesterone; Random Allocation; Recombinant Proteins; Sperm Injections, Intracytoplasmic; Triptorelin Pamoate | 2009 |
[Effect of desogestrel and ethinyl estradiol pretreatment in superovulation cycles with short protocol].
Topics: Adult; Clinical Protocols; Contraceptives, Oral, Combined; Desogestrel; Embryo Transfer; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Humans; Infertility, Female; Middle Aged; Ovulation Induction; Pregnancy; Pregnancy Rate; Retrospective Studies; Superovulation | 2008 |
Oral contraceptive pretreatment and half dose of ganirelix does not excessively suppress LH and may be an excellent choice for scheduling IUI cycles.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Insemination, Artificial; Luteinizing Hormone; Pregnancy; Reproductive Techniques, Assisted | 2008 |
Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women.
Topics: Adolescent; Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Risk Factors; Vasodilation; Young Adult | 2009 |
[NuvaRing-combined contraceptive vaginal ring: state of art in 2008. Expert Board of Polish Gynecological Society].
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Gynecology; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Medicated; Natural Family Planning Methods; Obstetrics; Patient Education as Topic; Poland; Pregnancy; Pregnancy, Unplanned; Women's Health | 2008 |
The vaginal ring: expelled or misplaced?
Topics: Adult; Desogestrel; Device Removal; Drug Combinations; Ethinyl Estradiol; Female; Foreign-Body Reaction; Humans; Prosthesis Implantation; Ultrasonography; Urinary Tract Infections | 2009 |
[The vaginal contraceptive ring].
Topics: Aftercare; Contraceptive Devices, Female; Contraindications; Desogestrel; Drug Combinations; Equipment Failure; Ethinyl Estradiol; Female; Humans; Patient Education as Topic; Patient Selection; Risk Factors; Sex Education | 2009 |
Extended regimens of the vaginal contraceptive ring: cycle control.
Topics: Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation Disturbances; Young Adult | 2009 |
Effect of injectable and oral contraceptives on serum lipids.
Topics: Adolescent; Adult; Black or African American; Cholesterol; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Hispanic or Latino; Humans; Hypercholesterolemia; Hypertriglyceridemia; Longitudinal Studies; Medroxyprogesterone Acetate; Triglycerides; White People; Young Adult | 2009 |
Probable drug interaction between warfarin and hormonal contraceptives.
Topics: Adult; Anticoagulants; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; International Normalized Ratio; Norethindrone; Warfarin | 2009 |
Extended regimens of the contraceptive vaginal ring: evaluation of clinical aspects.
Topics: Adolescent; Adult; Chi-Square Distribution; Contraceptive Devices, Female; Desogestrel; Drug Administration Schedule; Dysmenorrhea; Estrogens; Ethinyl Estradiol; Female; Headache; Humans; Prospective Studies; Time Factors; Treatment Outcome; Weight Gain | 2010 |
Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Homocysteine; Humans; Linear Models; Phenotype; Polycystic Ovary Syndrome; Prospective Studies; Statistics, Nonparametric | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Cerebral venous sinus thrombosis in a woman using the etonogestrel-ethinyl estradiol vaginal contraceptive ring: a case report.
Topics: Adult; Brain Death; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Fatal Outcome; Female; Humans; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 2010 |
Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
Topics: Adolescent; Adult; Contraceptives, Oral; Cross-Sectional Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Young Adult | 2011 |
[Vaginal combined contraception NuvaRing in the clinical practice in the Czech Republic].
Topics: Adult; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Patient Satisfaction; Young Adult | 2009 |
Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Middle Aged; Observation; Ovulation; Patient Satisfaction; Switzerland; Young Adult | 2010 |
Effect of injectable and oral contraceptives on glucose and insulin levels.
Topics: Adolescent; Adult; Blood Glucose; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Injections; Insulin; Medroxyprogesterone Acetate; Young Adult | 2011 |
Hormonal synchronization of the menstrual cycles of pigtail macaques to facilitate biomedical research including modeling HIV susceptibility.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Disease Models, Animal; Drug Combinations; Ethinyl Estradiol; Female; HIV; HIV Infections; Macaca nemestrina; Menstrual Cycle; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus | 2011 |
[Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].
Topics: Animals; Chromatography, Liquid; Desogestrel; Ethinyl Estradiol; Norpregnenes; Rabbits; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2010 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue.
Topics: Animals; Blood Coagulation; Contraceptives, Oral; Desogestrel; Estrogen Antagonists; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Mice; Mice, Inbred C57BL; Receptors, Estrogen; Receptors, Progesterone; Transcription, Genetic; Uterus | 2011 |
Drug synergistic antifertility effect of combined administration of low-dose gossypol with steroid hormones in rats.
Topics: Animals; Desogestrel; Epididymis; Ethinyl Estradiol; Flow Cytometry; Gossypol; Male; Random Allocation; Rats; Sperm Motility; Spermatogenesis; Spermatozoa; Testis; Testosterone | 2011 |
Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism.
Topics: Administration, Intravaginal; Adolescent; Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Lipids; Prospective Studies; Young Adult | 2011 |
Effect of a combination oral contraceptive (desogestrel+ethinyl estradiol) on the expression of low-density lipoprotein receptor and its transcription factor (SREBP2) in placental trophoblast cells.
Topics: Cell Line; Cells, Cultured; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Pregnancy; Receptors, LDL; Sterol Regulatory Element Binding Protein 2; Trophoblasts | 2011 |
[The influence of low-dose oral contraceptive pill on clinical and metabolic parameters in young women with polycystic ovary syndrome].
Topics: Adult; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Testosterone; Triglycerides; Young Adult | 2011 |
Extended regimens of the contraceptive vaginal ring versus hormonal oral contraceptives: effects on lipid metabolism.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Prospective Studies; Triglycerides | 2012 |
Reciprocal coordination of a combination oral contraceptive containing desogestrel+ethinyl estradiol on the expression of LOX-1 and LDLR in placental trophoblast cells.
Topics: Atherosclerosis; Cell Line; Cells, Cultured; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Down-Regulation; Ethinyl Estradiol; Female; Humans; Hypolipidemic Agents; Pregnancy Proteins; Receptors, LDL; Scavenger Receptors, Class E; Trophoblasts; Up-Regulation | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
Improving the efficiency of ion mobility spectrometry analyses by using multivariate calibration.
Topics: Algorithms; Calibration; Chromatography, High Pressure Liquid; Desogestrel; Ethinyl Estradiol; Ions; Multivariate Analysis; Principal Component Analysis; Software; Spectrophotometry; Tablets | 2012 |
Suspect online sellers and contraceptive access.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Counterfeit Drugs; Desogestrel; Drug Combinations; Drug Implants; Ethinyl Estradiol; Female; Humans; Injections; Intrauterine Devices; Medroxyprogesterone Acetate; Pharmaceutical Services, Online; Safety | 2012 |
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
Topics: Adult; Aldosterone; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Norpregnenes; Progestins; Renin; Renin-Angiotensin System; Young Adult | 2012 |
The impact of extended-cycle vaginal ring contraception on migraine aura: a retrospective case series.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Migraine with Aura; Pilot Projects; Retrospective Studies; Treatment Outcome | 2012 |
Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Topics: Adolescent; Adult; Androstenes; Arteries; California; Child; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Hospitalization; Humans; Incidence; Middle Aged; Myocardial Infarction; Norgestrel; Proportional Hazards Models; Risk Factors; Stroke; Tennessee; Thromboembolism; Time Factors; Venous Thromboembolism; Washington; Young Adult | 2013 |
Improving the prognosis ways of central genesis and management option in infertile women.
Topics: Adolescent; Adult; Amenorrhea; Androgen Antagonists; Carbamazepine; Central Nervous System Diseases; Cinnarizine; Cyproterone Acetate; Desogestrel; Drug Combinations; Electroencephalography; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oligomenorrhea; Progestins; Prognosis; Treatment Outcome; Young Adult | 2012 |
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors | 2013 |
Another flawed database study.
Topics: Androstenes; Contraceptive Agents, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Venous Thromboembolism | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study.
Topics: Administration, Intravaginal; Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Follicular Phase; Heart Rate; Humans; Hypertension; Prospective Studies; Severity of Illness Index; Young Adult | 2013 |
Investigating the feasibility of temperature-controlled accelerated drug release testing for an intravaginal ring.
Topics: Administration, Intravaginal; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Desogestrel; Diffusion; Drug Combinations; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Kinetics; Permeability; Polymers; Quality Control; Solubility; Temperature; Vagina | 2013 |
Cardiovascular risk associated with the use of an etonogestrel-containing vaginal ring.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Product Surveillance, Postmarketing; Prospective Studies; Risk Assessment; Venous Thromboembolism; Young Adult | 2013 |
Cerebral venous sinus thrombosis in the setting of combined vaginal contraception.
Topics: Adult; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; Sinus Thrombosis, Intracranial; Venous Thromboembolism | 2014 |
Significant decrease of ethinylestradiol with nevirapine, and of etonogestrel with efavirenz in HIV-positive women.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; HIV Infections; Humans; Nevirapine; Prospective Studies | 2014 |
A macroprolactin level today may keep health care cost and the surgical knife at bay.
Topics: Adolescent; Amenorrhea; Desogestrel; Diagnosis, Differential; Estrogens; Ethinyl Estradiol; Female; Health Expenditures; Humans; Hyperprolactinemia; Polycystic Ovary Syndrome; Progestins; Prolactin | 2015 |
Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: a prospective study.
Topics: Adiponectin; Adult; C-Peptide; C-Reactive Protein; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin-Like Growth Factor I; Leptin; Lipid Metabolism; Liver Function Tests; Longitudinal Studies; Mexico; Norgestrel; Oximes; Thyroid Function Tests; Transdermal Patch; Weight Gain | 2014 |
Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Contraception Behavior; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Middle Aged; Personal Satisfaction; Sexual Behavior; Sexuality; Time Factors | 2014 |
Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
Topics: Abdominoplasty; Administration, Intravaginal; Adult; Anticoagulants; Breast Implantation; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Embolectomy; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2015 |
Commentary on: Contraceptive Vaginal Rings: Do They Pose an Increased Risk of Venous Thromboembolism in Aesthetic Surgery?
Topics: Abdominoplasty; Breast Implantation; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis | 2015 |
Effect of a combined oral contraceptive on patency of arterial anastomosis in a female rat model.
Topics: Anastomosis, Surgical; Animals; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Femoral Artery; Microsurgery; Rats; Rats, Wistar; Vascular Surgical Procedures | 2015 |
Adult-onset Sydenham's chorea or drug-induced movement disorder? A case report.
Topics: Adult; Age of Onset; Chorea; Contraceptives, Oral, Hormonal; Desogestrel; Diagnosis, Differential; Ethinyl Estradiol; Female; Humans; Movement Disorders | 2016 |
Autoimmune progesterone dermatitis: Case report of an unexpected treatment reaction.
Topics: Administration, Intravaginal; Adult; Androstenes; Autoimmune Diseases; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Dermatitis; Desogestrel; Ethinyl Estradiol; Female; Humans; Luteal Phase; Progesterone; Urticaria | 2017 |
Stroke and Etonogestrel/Ethinyl Estradiol Ring (NuvaRing): Clinical, Radiological, and Prognostic Features.
Topics: Adolescent; Adult; Cerebral Angiography; Contraceptive Agents, Female; Databases, Factual; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Prognosis; Stroke; Tomography Scanners, X-Ray Computed; Young Adult | 2017 |
Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
Topics: Administration, Intravaginal; Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Kenya; Patient Compliance; United States | 2017 |
Weight gain, body image and sexual function in young patients treated with contraceptive vaginal ring. A prospective pilot study.
Topics: Adolescent; Adult; Body Dysmorphic Disorders; Body Mass Index; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Health Knowledge, Attitudes, Practice; Humans; Italy; Overweight; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Weight Gain; Young Adult | 2017 |
Establishment of a Molding Procedure to Facilitate Formulation Development for Co-extrudates.
Topics: Chemistry, Pharmaceutical; Delayed-Action Preparations; Desogestrel; Drug Combinations; Drug Compounding; Drug Liberation; Ethinyl Estradiol; Vacuum | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Simultaneous determination of etonogestrel and ethinyl estradiol in human plasma by UPLC-MS/MS and its pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Desogestrel; Ethinyl Estradiol; Female; Humans; Limit of Detection; Linear Models; Reproducibility of Results; Tandem Mass Spectrometry | 2018 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
The Effects of Sex Differences and Hormonal Contraception on Outcomes after Collegiate Sports-Related Concussion.
Topics: Athletic Injuries; Brain Concussion; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Male; Recovery of Function; Sex Characteristics; Students; Universities; Young Adult | 2018 |
Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
Topics: Abortion, Incomplete; Abortion, Induced; Abortion, Spontaneous; Adult; Choice Behavior; Contraceptives, Oral, Combined; Desogestrel; Dilatation and Curettage; Ethinyl Estradiol; Female; Humans; Misoprostol; Pilot Projects; Pregnancy; Pregnancy Trimester, First; Retrospective Studies; Tablets; Treatment Failure; Uterine Hemorrhage | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM).
Topics: Biomass; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Microscopy, Electron, Scanning; Polyvinyls; Surface Properties; Vagina | 2020 |
Elution from intact and broken vaginal contraceptive rings: an in vitro study.
Topics: Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Delivery Systems; Ethinyl Estradiol; Female; Humans; Materials Testing | 2020 |
Metformin metabolic and vascular effects in normal weight hyperinsulinemic polycystic ovary syndrome patients treated with contraceptive vaginal ring. A pilot study.
Topics: Adult; Blood Glucose; Brachial Artery; Contraceptive Agents, Hormonal; Contraceptive Devices, Female; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Longitudinal Studies; Metformin; Ophthalmic Artery; Pilot Projects; Polycystic Ovary Syndrome; Retrospective Studies; Ultrasonography, Doppler; Vasodilation; Young Adult | 2020 |
Development of a simple liquid chromatography method for dissolution testing of low dose desogestrel and ethinylestradiol tablets.
Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Desogestrel; Ethinyl Estradiol; Solubility; Tablets | 2020 |
Double-Dose Desogestrel: Is it Effective in Adolescent Menstrual Dysfunction?
Topics: Adolescent; Amenorrhea; Child; Desogestrel; Ethinyl Estradiol; Female; Humans; Metrorrhagia; Retrospective Studies | 2021 |
A NuvaRing caught in the wrong spot.
Topics: Desogestrel; Drug Combinations; Ethinyl Estradiol; Humans | 2022 |
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |
Long-term treatment of endometriosis-related pain among women seeking hormonal contraception.
Topics: Contraception; Contraceptives, Oral, Combined; Desogestrel; Endometriosis; Ethinyl Estradiol; Female; Hormonal Contraception; Humans; Male; Pelvic Pain; Progesterone Congeners; Progestins; Retrospective Studies | 2022 |
"Double-dose desogestrel: Is it effective in adolescent menstrual dysfunction?" - Response to Güven et al.
Topics: Adolescent; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation | 2022 |
"Double-dose desogestrel: Is it effective in adolescent menstrual dysfunction?"
Topics: Adolescent; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Menstruation | 2022 |
The progestin-only pills drospirenone 4 mg and desogestrel 0.075 mg as an option for the management of dysmenorrhea and mastodynia.
Topics: Contraceptives, Oral, Combined; Desogestrel; Dysmenorrhea; Ethinyl Estradiol; Female; Humans; Mastodynia; Pregnancy; Progesterone Congeners; Progestins | 2022 |